Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014791	s-lipob	g/l (g/l)	15756	16695	0.00%
3014791	fs-lipob	g/l (g/l)	3657	5505	0.00%
3014791	p-lipob	g/l_______ (g/l)	110	118	0.00%
3014791	s-lipob	— (—)	81	86	100.00%	Distribution not available
3014791	fs-lipob	— (—)	75	81	100.00%	Distribution not available
3014791	p-lipob	— (—)	24	25	100.00%	Distribution not available
3014791	p-lipob	g/l (g/l)	19	19	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any mental disorder

1777

15517

0.56

115.88

1.2

1.1

0.89

g/l

0.03

1772

15473

Mood disorders, excluding more controls

1497

15508

0.56

103.58

1.2

1.1

0.89

g/l

0.05

1491

15464

Type 2 diabetes, wide definition

783

10654

0.45

103.25

1.4

1.2

0.84

0.91

g/l

8.97

774

10621

Benzodiazepine use

1487

17392

0.57

97.39

1.3

1.1

0.89

g/l

0.51

1476

17342

Other bacterial diseases

1281

14944

0.56

89.05

1.4

1.2

0.89

g/l

0.17

1274

14894

Diabetes, insulin treatment (Kela reimbursement)

1491

15017

0.58

88.21

1.3

1.2

0.82

0.90

g/l

26.89

1479

14975

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1451

14533

0.58

85.13

1.3

1.1

0.82

0.90

g/l

26.99

1440

14496

Mood disorders

1692

17529

0.61

84.40

1.2

1.1

0.89

g/l

0.04

1683

17477

Mood [affective] disorders

1695

17525

0.61

83.23

1.2

1.1

0.89

g/l

0.04

1686

17473

Condition for Implicit Sepsis (Organ dysfunction codes)

1096

13648

0.55

82.29

1.5

1.1

0.88

0.89

g/l

0.95

1088

13605

Personality disorders, excluding more controls

290

8282

0.34

79.26

1.2

1.1

0.90

0.88

g/l

0.45

285

8266

Depression

1635

17494

0.61

77.78

1.2

1.1

0.88

0.89

g/l

0.26

1626

17445

Heart failure, not strict

572

8369

0.45

77.48

1.8

1.2

0.89

g/l

0.16

564

8339

Persons encountering health services for specific procedures and health care

1885

17185

0.64

75.27

1.3

1.1

0.89

g/l

0.08

1878

17137

Schizophrenia

3986

0.09

74.83

1.1

1.2

0.90

g/l

0.01

3980

Symptoms and signs involving cognition, perception, emotional state and behaviour

1481

15958

0.61

72.60

1.2

0.88

0.89

g/l

0.49

1475

15904

Insulin medication

601

10349

0.47

72.46

1.5

1.2

0.78

0.90

g/l

22.08

594

10321

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1465

15932

0.61

72.03

1.4

1.1

0.88

0.89

g/l

0.35

1458

15879

Bleeding

880

11351

0.53

71.54

1.4

1.2

0.89

g/l

0.23

875

11306

Implicit Sepsis, including avohilmo

1033

12943

0.56

71.12

1.5

1.2

0.88

0.89

g/l

0.76

1024

12901

Other bacterial diseases, including avohilmo

1696

16398

0.64

69.02

1.3

1.1

0.88

0.89

g/l

0.52

1687

16344

Implicit Sepsis

800

10956

0.53

67.70

1.6

1.2

0.88

0.89

g/l

0.24

792

10914

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1406

15109

0.62

65.36

1.4

1.1

0.87

0.89

g/l

2.43

1396

15063

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1693

17204

0.65

64.68

1.3

1.1

0.89

g/l

0.42

1688

17147

Diabetes mellitus

1866

16171

0.66

64.66

1.3

1.1

0.84

0.90

g/l

16.96

1856

16130

Anxiety disorders, excluding more controls

1558

15449

0.63

64.57

1.2

1.1

0.89

g/l

0.08

1553

15409

Diabetes medication

1850

16192

0.66

63.68

1.3

1.1

0.83

0.90

g/l

18.91

1840

16148

All anxiety disorders

1265

15808

0.61

63.35

1.2

1.1

0.88

0.89

g/l

0.34

1260

15772

Diabetes, varying definitions

1862

16129

0.66

63.13

1.3

1.1

0.84

0.90

g/l

16.45

1852

16088

Personality disorders

290

7488

0.37

63.02

1.2

1.1

0.90

0.88

g/l

0.43

285

7473

Other disorders of ear

1296

13468

0.61

62.57

1.2

0.89

g/l

0.19

1289

13425

Type 2 diabetes

1738

15162

0.65

61.56

1.3

1.1

0.85

0.90

g/l

10.08

1729

15121

Pneumonias (Asthma/COPD co-morbidities)

1788

17369

0.66

60.02

1.3

1.1

0.89

g/l

0.43

1783

17312

All pneumoniae

1815

17397

0.67

58.40

1.3

1.1

0.89

g/l

0.45

1810

17340

Polyarthropathies

1047

11169

0.59

58.21

1.3

1.1

0.87

0.89

g/l

1.63

1041

11140

Insulin, combination of fast acting with intermediate-acting or long-acting

601

10471

0.51

57.54

1.5

1.2

0.78

0.90

g/l

19.95

594

10438

All kidney diseases

1656

16463

0.66

55.03

1.4

1.1

0.88

g/l

0.11

1645

16416

Spondylopathies

1137

10826

0.61

54.90

1.2

0.89

g/l

0.03

1125

10795

Metabolic disorders

1615

14457

0.66

54.65

1.3

1.2

0.88

0.89

g/l

1.13

1606

14420

Dyspnoea

1295

14545

0.63

54.55

1.2

0.88

g/l

0.37

1285

14499

Renal tubulo-interstitial diseases

1169

13539

0.62

52.93

1.5

1.2

0.89

0.88

g/l

0.55

1160

13492

Biguanides

1547

13919

0.66

51.99

1.3

1.2

0.85

0.90

g/l

8.24

1537

13878

Other (not insulin) diabetes medications

1672

14381

0.67

51.35

1.3

1.1

0.85

0.90

g/l

9.01

1662

14339

STROKE

680

8193

0.55

50.57

1.3

1.2

0.84

0.91

g/l

8.70

673

8174

Anxiety disorders

1744

17273

0.68

50.42

1.2

1.1

0.89

g/l

0.01

1738

17224

Neurotic, stress-related and somatoform disorders

1737

17264

0.68

50.09

1.2

1.1

0.89

g/l

0.02

1731

17216

Cerebrovascular diseases

596

7654

0.53

49.54

1.3

1.2

0.83

0.90

g/l

7.00

588

7620

Erysipelas, including avohilmo

1004

11892

0.62

47.97

1.3

1.2

0.88

0.90

g/l

2.41

996

11849

Insulin, intermediate and long-acting

535

9698

0.52

47.97

1.4

1.2

0.78

0.90

g/l

20.55

528

9668

Disorders of lipoprotein metabolism and other lipidaemias

1217

11374

0.64

47.76

1.3

1.2

0.88

0.90

g/l

1.30

1207

11340

Care involving use of rehabilitation procedures

900

13175

0.60

47.27

1.2

0.89

g/l

0.13

895

13135

Type 2 diabetes, strict (exclude DM1)

1696

14165

0.69

46.52

1.3

1.1

0.86

0.90

g/l

7.13

1685

14126

Type 2 diabetes, definitions combined

1694

14147

0.69

46.46

1.3

1.1

0.86

0.90

g/l

7.22

1683

14108

Complications of surgical and medical care, not elsewhere classified

1670

15984

0.69

46.26

1.3

1.2

0.89

0.88

g/l

0.53

1660

15933

Bipolar affective disorders

201

5277

0.37

45.69

1.2

1.1

0.90

0.88

g/l

0.49

201

5268

Diseases of oesophagus, stomach and duodenum

1956

16080

0.71

44.91

1.3

1.1

0.90

0.89

g/l

1.24

1948

16029

Disorders of choroid and retina

914

10312

0.61

44.89

1.3

1.2

0.84

0.90

g/l

9.00

906

10272

Use of hypnotics and sedatives

1965

15534

0.71

43.17

1.3

1.2

0.90

0.89

g/l

0.92

1951

15493

Influenza and pneumonia

2054

17366

0.72

42.95

1.3

1.1

0.89

0.88

g/l

0.23

2048

17310

Constipation

1240

12547

0.66

42.60

1.4

1.2

0.87

0.89

g/l

1.92

1231

12504

Persons encountering health services in other circumstances, wide

2271

15793

0.73

42.59

1.2

1.1

0.89

g/l

0.06

2259

15749

Hard cardiovascular diseases

1285

11271

0.66

42.42

1.3

1.2

0.83

0.91

g/l

19.85

1279

11242

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3106

15290

1.32

41.92

1.2

1.1

0.89

g/l

0.10

3094

15240

Type 2 diabetes, definitions combined, including avohilmo

1759

14241

0.71

41.80

1.3

1.1

0.87

0.90

g/l

4.35

1749

14203

Pain in limb

1514

13744

0.69

40.93

1.2

1.1

0.90

0.88

g/l

1.58

1503

13713

Stroke, including SAH

411

5765

0.51

40.90

1.4

1.2

0.83

0.90

g/l

4.57

405

5741

Periodontitis

1781

15742

0.71

40.36

1.3

1.2

0.90

0.89

g/l

0.32

1767

15701

Chronic periodontitis, including avohilmo

1785

15714

0.72

39.19

1.3

1.2

0.90

0.89

g/l

0.28

1771

15673

Hypertension

1650

13013

0.70

39.09

1.3

1.1

0.87

0.90

g/l

8.23

1645

12980

Other heart diseases, wide

1944

16016

0.72

39.08

1.2

1.1

0.88

0.89

g/l

1.13

1937

15979

Hypertensive diseases

1651

13018

0.70

39.02

1.3

1.1

0.87

0.90

g/l

8.25

1646

12985

Selective serotonin reuptake inhibitors

1997

14118

0.73

38.90

1.2

1.1

0.88

0.89

g/l

0.56

1989

14082

Other antidepressants

2039

14109

0.73

38.81

1.2

1.1

0.88

0.89

g/l

0.34

2033

14073

Conjunctivitis (acute, non atopic), including avohilmo

3084

14415

1.31

38.77

1.2

0.89

g/l

0.13

3069

14372

Tramadol

1458

12490

0.69

38.63

1.4

1.1

0.90

0.89

g/l

1.14

1445

12464

Pure hypercholesterolaemia

1025

9907

0.65

38.61

1.3

1.2

0.89

0.90

g/l

0.41

1016

9875

Alcohol abuse, main dg, excluding more controls

130

3839

0.33

38.11

1.3

1.2

0.90

0.89

g/l

0.10

130

3830

Ischemic heart diseases

1216

10636

0.67

38.07

1.3

1.2

0.84

0.91

g/l

13.80

1208

10608

Malignant neoplasm

1586

12992

0.71

37.61

1.3

1.2

0.91

0.89

g/l

3.02

1580

12950

Malignant neoplasm

1590

12982

0.71

36.98

1.3

1.2

0.91

0.89

g/l

3.08

1584

12940

Acute alcohol intoxication, ICD10

178

4498

0.38

36.89

1.3

1.2

0.90

0.89

g/l

0.13

178

4488

Other arrhythmias

1033

11532

0.66

36.33

1.2

0.88

0.89

g/l

0.53

1025

11504

Ischaemic heart disease, wide definition

882

8386

0.64

35.54

1.4

1.2

0.82

0.91

g/l

15.00

871

8366

Other retinal disorders

546

7141

0.57

35.31

1.3

1.2

0.82

0.90

g/l

10.70

540

7109

Disorders of lens

724

7212

0.62

34.84

1.5

1.2

0.86

0.90

g/l

2.96

717

7188

Major coronary heart disease event

1172

10187

0.68

34.57

1.3

1.2

0.84

0.91

g/l

15.65

1162

10156

Solid cancers

1550

12553

0.71

34.12

1.3

1.2

0.91

0.89

g/l

2.62

1543

12512

Erysipelas

622

8800

0.60

33.75

1.3

1.2

0.88

0.90

g/l

1.43

616

8767

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2273

15789

0.76

33.74

1.2

1.1

0.88

0.89

g/l

0.43

2259

15746

Spondylosis

661

8361

0.61

33.69

1.2

0.90

0.89

g/l

0.16

651

8332

Malignant neoplasm, wide definition

1707

13494

0.73

33.66

1.3

1.2

0.91

0.89

g/l

2.73

1702

13450

Major coronary heart disease event excluding revascularizations

486

5635

0.56

33.65

1.4

1.2

0.79

0.90

g/l

16.40

480

5620

Chronic apical periodontitis

2259

16527

0.76

33.27

1.2

1.1

0.90

0.88

g/l

2.56

2252

16476

Other soft tissue disorders, not elsewhere classified

1883

14301

0.74

32.93

1.2

1.1

0.89

0.88

g/l

1.07

1873

14269

Malignant neoplasm, including Hilmo

1715

13505

0.73

32.85

1.3

1.2

0.91

0.89

g/l

2.91

1710

13461

Persons encountering health services in other circumstances

579

9421

0.60

32.23

1.2

1.1

0.88

g/l

0.23

574

9403

Solid cancers, including Hilmo

1659

13095

0.73

32.19

1.3

1.2

0.91

0.89

g/l

2.50

1653

13052

Stroke, excluding SAH

378

5056

0.53

31.76

1.4

1.2

0.82

0.90

g/l

6.48

372

5036

General symptoms and signs

2369

15325

0.77

31.75

1.2

1.1

0.89

g/l

0.06

2359

15283

Cardiac arrhythmias

1430

12623

0.71

31.55

1.2

1.1

0.88

0.90

g/l

2.53

1425

12607

Bacterial Sepsis

332

5188

0.52

30.16

1.9

1.2

0.89

g/l

0.05

327

5165

Disorders of gallbladder, biliary tract and pancreas

1660

13843

0.74

30.03

1.4

1.1

0.90

0.89

g/l

1.23

1651

13797

Bacterial infection, other or unspecified, including avohilmo

592

7822

0.61

29.72

1.6

1.2

0.89

g/l

0.13

592

7786

Lower back pain or/and sciatica

2115

17000

0.77

29.50

1.2

0.89

0.88

g/l

0.52

2104

16947

Finngen Rheumatological endpoints

2098

15429

0.76

29.46

1.2

1.1

0.89

g/l

0.06

2093

15386

Alcohol abuse, main dg

130

3401

0.37

29.37

1.3

1.2

0.90

0.89

g/l

0.14

130

3393

Any event in cancer register

1878

14344

0.76

28.49

1.2

1.1

0.90

0.88

g/l

3.03

1871

14299

Coronary revascularization (ANGIO or CABG)

1155

9845

0.70

28.12

1.3

1.2

0.83

0.91

g/l

16.01

1146

9817

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1896

15602

0.76

28.02

1.5

1.1

0.88

g/l

0.16

1891

15554

Emergency coronary revascularization (for ACS)

1183

9956

0.71

27.57

1.3

1.2

0.83

0.91

g/l

16.49

1173

9922

Percutaneous Coronary Intervention

1157

9838

0.71

27.57

1.3

1.2

0.83

0.91

g/l

16.24

1148

9810

Low back pain

1552

13939

0.74

27.13

1.2

1.1

0.89

0.88

g/l

0.55

1544

13903

Implicit bacterial Sepsis, including avohilmo

313

4822

0.53

26.65

1.9

1.2

0.88

0.89

g/l

0.25

308

4799

Spinal stenosis

403

5125

0.57

26.42

1.3

1.2

0.88

0.89

g/l

0.21

397

5101

Dizziness and giddiness

1117

12057

0.71

26.06

1.2

0.88

0.89

g/l

0.52

1112

12014

Dorsalgia

2128

14361

0.78

25.82

1.2

1.1

0.89

0.88

g/l

1.22

2118

14324

Ischaemic Stroke, excluding all haemorrhages

332

4419

0.55

25.77

1.4

1.2

0.81

0.90

g/l

6.74

326

4401

Any reimbursement code in KELA

1749

11415

0.76

25.53

1.2

1.1

0.87

0.90

g/l

4.66

1743

11394

Other inflammation of eyelid, including avohilmo

1513

11403

1.35

25.48

1.1

0.88

g/l

0.28

1504

11378

Pain in throat and chest

1852

14147

0.77

25.41

1.2

1.1

0.87

0.89

g/l

1.69

1842

14109

Complications of procedures, not elsewhere classified

1396

15000

0.74

25.24

1.3

1.2

0.89

0.88

g/l

0.57

1387

14950

Complications of medical and surgical care

1092

13565

0.72

25.19

1.3

1.2

0.89

0.88

g/l

0.51

1085

13518

Bacterial infection, other or unspecified

497

6761

0.61

25.08

1.7

1.2

0.90

0.89

g/l

0.33

497

6732

COPD related to multimorbidity

114

2523

0.38

25.04

1.4

1.3

0.88

0.89

g/l

0.19

114

2506

Heart failure and coronary heart disease

158

2537

0.43

24.93

1.4

1.3

0.91

0.90

g/l

0.07

152

2529

Senile cataract

547

5273

0.62

24.92

1.5

1.2

0.86

0.89

g/l

2.98

540

5252

Implicit bacterial Sepsis

256

4222

0.51

24.77

2.1

1.2

0.88

0.89

g/l

0.23

251

4200

Autoimmune diseases

2448

15467

0.80

24.18

1.2

1.1

0.87

0.89

g/l

1.92

2442

15414

Primary biliary cholangitis, wide definition

296

3.38

24.05

3.0

1.2

0.87

0.91

g/l

0.88

296

Angina pectoris

458

4953

0.61

23.78

1.4

1.2

0.82

0.90

g/l

7.06

451

4941

Dipeptidyl peptidase 4 (DPP-4) inhibitors

460

5839

0.61

23.52

1.5

1.2

0.86

0.90

g/l

2.18

454

5814

COPD (mode)

153

2694

0.44

23.47

1.3

1.2

0.90

0.89

g/l

0.13

153

2674

Insomnia

2800

15900

1.24

23.23

1.1

1.2

0.89

g/l

0.04

2790

15858

Coxarthrosis [arthrosis of hip](FG)

588

6185

0.65

22.97

1.3

1.2

0.91

0.89

g/l

0.79

583

6158

Mental retardation, excluding more controls

751

0.10

22.31

1.0

1.1

0.90

0.89

g/l

—

751

Diverticular disease of intestine

966

8350

0.71

22.16

1.4

1.2

0.90

0.89

g/l

0.47

959

8316

Used for control exclusion in common control thyroid runs

2398

14900

0.80

21.59

1.2

1.1

0.88

0.89

g/l

1.70

2392

14849

Other neurological diseases

825

9044

0.70

21.52

1.3

1.2

0.85

0.89

g/l

4.52

818

9007

Chronic periodontitis, complicated

702

9877

0.69

21.12

1.3

1.2

0.91

0.89

g/l

0.59

691

9844

Sleep disorders

2782

15787

1.22

21.02

1.1

1.2

0.89

g/l

0.06

2772

15745

Nerve, nerve root and plexus disorders

2112

15756

0.80

21.01

1.2

0.89

g/l

0.23

2095

15711

Acute tubulo-interstitial nephritis

748

9022

0.69

20.95

1.3

1.2

0.88

0.87

g/l

0.54

743

8986

Colitis, primary sclerosing

257

3.47

20.79

2.8

1.1

0.87

0.90

g/l

0.62

257

Endocrine, nutritional and metabolic diseases

2113

13256

0.80

20.77

1.2

1.1

0.87

0.89

g/l

3.79

2106

13229

Myocardial infarction, strict

336

4008

0.59

20.21

1.4

1.3

0.77

0.90

g/l

13.98

330

3999

Shoulder lesions

1418

10992

0.77

20.00

1.2

0.89

g/l

0.72

1409

10968

Symptoms and signs involving the nervous and musculoskeletal systems

761

10692

0.70

19.66

1.2

0.89

0.88

g/l

0.06

756

10653

Colitis, primary sclerosing, strict definition

211

3.72

19.59

2.8

1.1

0.85

0.90

g/l

0.97

211

Obesity due to excess calories

854

11745

0.72

19.50

1.2

0.88

g/l

0.08

847

11723

Gastro-oesophageal reflux disease

1138

12673

0.75

19.37

1.2

0.90

0.89

g/l

0.60

1132

12630

COPD, hospital admission 2, with asthma infections

111

2259

0.42

19.31

1.4

1.3

0.90

0.89

g/l

0.21

111

2249

Injuries to the head

2354

16977

0.82

19.00

1.2

0.89

0.88

g/l

0.19

2342

16925

Mental retardation, wide definition

685

0.11

18.98

1.0

1.2

0.90

g/l

—

685

Cholelithiasis, broad definition with cholecystitis

1368

11718

0.77

18.70

1.3

1.2

0.89

0.88

g/l

1.11

1358

11676

All chronic kidney diseases

594

6911

0.68

18.67

1.7

1.2

0.88

0.89

g/l

0.21

589

6887

Oral corticosteroids

2202

15770

0.81

18.66

1.2

1.1

0.88

0.89

g/l

0.62

2193

15721

Intestinal infectious diseases, including avohilmo, including avohilmo

3213

15060

1.20

18.66

1.2

1.1

0.89

g/l

0.02

3200

15011

Rotator cuff syndrome

1010

9300

0.74

18.51

1.2

0.89

0.90

g/l

0.43

1001

9279

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1154

9527

0.75

18.40

1.3

1.1

0.89

0.91

g/l

1.07

1148

9513

Behavioural syndromes associated with physiological disturbances and physical factors

2803

15862

1.20

18.12

1.1

1.2

0.89

g/l

0.10

2793

15820

Mental retardation

661

0.12

18.01

1.0

1.2

0.90

g/l

—

661

Other diseases of intestines

2440

16378

0.82

17.87

1.2

1.1

0.89

0.88

g/l

0.91

2435

16328

Depression or dysthymia

1292

9104

0.77

17.72

1.2

0.90

0.89

g/l

1.24

1287

9078

Periapical abscess

792

10808

0.72

17.27

1.2

0.91

0.89

g/l

1.31

786

10782

Cholangitis (primary sclerosing, PSC), with reimbursement 202

298

2.97

17.03

3.0

1.2

0.86

0.91

g/l

1.16

298

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1802

14044

0.80

16.96

1.3

1.2

0.89

g/l

0.26

1792

13998

Other disorders of fluid, electrolyte and acid-base balance

200

3439

0.54

16.60

1.7

1.2

0.88

0.89

g/l

0.26

200

3429

Other intervertebral disc disorders

1746

12852

0.80

16.56

1.2

0.90

0.89

g/l

1.88

1738

12818

Cholelithiasis

1316

11430

0.78

16.52

1.3

1.2

0.89

0.88

g/l

0.84

1307

11391

COPD, hospital admissions 3, with asthma pneumonia sepsis

1485

0.35

15.96

1.5

1.3

0.91

0.89

g/l

0.20

1475

Hypertensive heart and/or renal disease

107

1736

0.45

15.84

1.4

1.2

0.86

0.90

g/l

0.98

102

1728

Diabetic retinopathy, excluding more controls

170

1811

0.52

15.78

1.4

1.3

0.78

0.84

g/l

2.10

170

1796

Syncope and collapse

559

6654

0.69

15.65

1.3

1.2

0.86

0.88

g/l

1.82

552

6635

Other disorders of skin and subcutaneous tissue

1048

11468

0.77

15.63

1.3

1.2

0.88

0.89

g/l

0.78

1043

11425

Dementia, including avohilmo

1477

0.43

15.42

1.4

0.87

0.88

g/l

0.19

1461

Diabetic retinopathy

187

2126

0.54

15.34

1.4

1.3

0.79

0.84

g/l

2.04

187

2106

Fall on same level

2636

16568

0.84

15.05

1.2

1.1

0.89

0.88

g/l

0.79

2625

16522

Septicaemia

361

5054

0.65

14.94

1.8

1.2

0.89

g/l

0.01

361

5030

Infections of the skin and subcutaneous tissue

1164

14412

0.79

13.94

1.2

0.89

g/l

0.00

1158

14377

Abnormalities of breathing

2120

14447

0.83

13.91

1.2

1.1

0.88

0.89

g/l

0.38

2115

14410

Recurrent or chronic depression

968

8656

0.77

13.87

1.2

1.1

0.89

g/l

0.05

963

8634

Panic disorder

270

4294

0.62

13.67

1.2

1.1

0.89

0.88

g/l

0.48

270

4285

Soft tissue disorders

2400

14489

0.84

13.65

1.2

1.1

0.89

0.88

g/l

0.38

2391

14456

Obesity

1264

14793

0.80

13.55

1.2

0.88

g/l

0.10

1256

14755

Primary biliary cholangitis (PBC)

275

2.77

13.53

2.6

1.2

0.89

0.91

g/l

0.33

275

Obesity and other hyperalimentation

1271

14835

0.80

13.48

1.2

0.88

g/l

0.08

1263

14797

Chronic diseases of tonsils and adenoids

2461

13190

1.19

13.35

1.1

1.2

0.89

g/l

0.55

2454

13152

Headache

1530

14380

0.81

13.10

1.1

0.89

0.88

g/l

0.72

1523

14342

Dermatophytosis, including avohilmo

1847

15113

1.21

12.98

1.2

0.89

g/l

0.02

1839

15069

Hypertensive Heart Disease

1512

0.46

12.87

1.4

1.2

0.86

0.90

g/l

0.94

1505

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1414

0.42

12.76

1.7

1.3

0.94

0.89

g/l

1.00

1401

Exclusions for E4_PCOS_CONSORTIUM

1479

11262

0.81

12.74

1.2

1.1

0.89

0.88

g/l

2.13

1474

11233

Pain in joint

1335

10106

0.80

12.68

1.2

1.1

0.89

0.88

g/l

0.27

1328

10079

Disorders of eyelid, lacrimal system and orbit

1522

13538

0.82

12.61

1.2

0.88

g/l

0.06

1515

13489

Other arthrosis

904

7787

0.77

12.54

1.3

1.2

0.88

0.90

g/l

1.18

897

7765

IBD (strict) with PSC

205

3.09

12.38

2.9

1.1

0.88

0.90

g/l

0.29

205

Other nutritional deficiencies

1357

15116

0.81

12.15

1.2

0.88

g/l

0.09

1349

15076

Other septicaemia, including avohilmo

322

4516

0.66

11.81

1.8

1.2

0.89

g/l

0.11

322

4492

Dorsopathies

2451

14430

0.85

11.76

1.1

0.90

0.88

g/l

2.25

2442

14393

Lung cancer and mesothelioma

1165

0.38

11.72

1.9

1.3

0.97

0.89

g/l

1.27

1155

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1639

13100

1.21

11.69

1.1

0.87

0.89

g/l

3.13

1634

13065

Ulcerative colitis (strict) with PSC

163

3.30

11.59

2.9

1.1

0.89

0.91

g/l

0.11

163

Other/unspecified dorsalgia

604

7968

0.74

11.59

1.2

0.89

0.88

g/l

0.51

599

7949

Sequelae of cerebrovascular disease

196

2783

0.60

11.54

1.4

1.3

0.80

0.89

g/l

4.11

191

2769

Factors influencing health status and contact with health services

743

4868

0.76

11.34

1.2

1.1

0.90

g/l

0.15

743

4853

Falls/tendency to fall

2584

14945

0.86

11.30

1.2

1.1

0.89

0.88

g/l

0.37

2577

14901

Dissocial personality disorder

408

0.12

11.23

2.0

1.2

1.02

0.93

g/l

—

408

Malignant neoplasm of bronchus and lung, including Hilmo

1100

0.38

11.23

1.9

1.3

0.97

0.89

g/l

1.39

1088

Malignant neoplasm of respiratory system and intrathoracic organs

1199

0.41

11.18

1.8

1.3

0.96

0.89

g/l

1.35

1187

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

903

11178

0.79

11.17

1.3

1.2

0.89

0.88

g/l

0.17

897

11140

Other septicaemia

313

4383

0.67

11.16

1.8

1.2

0.89

g/l

0.10

313

4360

Caries of enamel

2805

15997

1.15

11.00

1.2

0.88

0.89

g/l

1.18

2800

15944

Allergic conjunctivitis

1684

13634

1.20

10.98

1.1

0.87

0.89

g/l

3.46

1679

13599

Any gastric operation

2113

12386

0.85

10.91

1.2

1.1

0.90

0.88

g/l

2.77

2106

12357

GASTRO-related operations

2113

12386

0.85

10.91

1.2

1.1

0.90

0.88

g/l

2.77

2106

12357

Lumbar disc prolapse

1364

12195

0.82

10.84

1.2

0.90

0.89

g/l

1.13

1358

12163

Second line medication for Crohn's disease

1036

12801

0.80

10.75

1.2

0.87

0.89

g/l

1.66

1036

12762

Certain infectious and parasitic diseases

2289

13298

0.86

10.67

1.2

1.1

0.88

0.89

g/l

1.34

2279

13259

Other dorsopathies, not elsewhere classified

2401

14399

0.86

10.61

1.2

1.1

0.90

0.88

g/l

2.09

2393

14362

Propionic acid derivatives

663

2504

1.34

10.53

1.2

1.1

0.88

g/l

0.30

663

2494

Other specific joint derangements/joint disorders

1813

13287

0.84

10.52

1.2

1.1

0.89

0.88

g/l

0.81

1805

13258

Hyperlipidaemia, other/unspecified

303

4021

0.67

10.49

1.4

1.2

0.87

0.89

g/l

0.54

297

4007

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2482

16794

1.16

10.40

1.2

1.1

0.87

0.89

g/l

2.76

2473

16741

malignant neoplasm of male genital organs, including Hilmo

240

2240

0.64

10.37

1.3

1.2

0.89

0.88

g/l

0.15

240

2226

Assault

279

4104

0.67

9.94

1.2

1.1

0.90

g/l

0.05

279

4099

COPD/asthma related infections

2280

13172

0.86

9.89

1.2

1.1

0.88

g/l

0.10

2274

13127

COPD/asthma/ILD related infections

2280

13172

0.86

9.89

1.2

1.1

0.88

g/l

0.10

2274

13127

Varicose veins

723

6974

0.78

9.69

1.2

0.89

g/l

0.11

716

6947

Dissociative [conversion] disorders

869

0.31

9.56

1.2

1.1

0.83

0.86

g/l

0.39

869

Fracture of lower leg, including ankle

981

11827

0.81

9.56

1.2

0.90

0.89

g/l

0.71

975

11792

L04AX Other immunosuppressants

994

12164

0.81

9.43

1.2

0.87

0.89

g/l

1.55

994

12128

Pain (limb, back, neck, head abdominally)

1738

10208

0.85

9.38

1.2

1.1

0.89

0.88

g/l

0.70

1732

10181

Mycoses, including avohilmo

2536

16956

1.14

9.18

1.2

0.88

0.89

g/l

0.12

2526

16903

Other and unspecified effects of external causes

500

6600

0.75

9.04

1.1

0.86

0.88

g/l

1.12

494

6588

Osteopathies and chondropathies

822

9335

0.80

8.91

1.4

1.2

0.89

g/l

0.06

815

9305

Episodal and paroxysmal disorders

2544

14658

0.88

8.88

1.2

1.1

0.89

g/l

0.40

2538

14619

Malignant neoplasm of bronchus and lung

895

0.40

8.78

2.0

1.3

0.98

0.89

g/l

1.36

885

Hernia

1958

14970

0.86

8.64

1.2

0.90

0.89

g/l

0.65

1950

14921

Inflammatory bowel disease treatment related agents

2623

16437

0.88

8.55

1.2

1.1

0.88

0.89

g/l

0.98

2615

16386

Carpal tunnel syndrome

1073

11194

0.82

8.52

1.1

1.2

0.88

0.89

g/l

0.37

1065

11165

Renal failure

363

4260

0.72

8.51

2.1

1.2

0.91

0.89

g/l

0.82

358

4239

Parasetamol

2044

11864

0.87

8.46

1.2

1.1

0.89

g/l

0.63

2038

11838

Diabetic retinopathy, strict definition

1598

0.54

8.43

1.2

1.3

0.75

0.84

g/l

2.63

1587

Malignant neoplasm of prostate, including Hilmo

202

1832

0.65

8.37

1.3

1.2

0.87

g/l

0.00

202

1818

Asthma/COPD (KELA code 203)

2164

16480

0.87

8.32

1.2

0.87

0.89

g/l

2.40

2158

16423

Opioids

2463

14408

0.88

8.32

1.2

1.1

0.90

0.88

g/l

2.19

2451

14380

Persons encountering health services in circumstances related to reproduction

1919

11169

1.16

8.28

1.2

0.91

0.90

g/l

1.21

1913

11139

External causes of morbidity and mortality

1599

9354

0.85

8.27

1.2

1.1

0.88

g/l

0.26

1594

9329

Exclusions for E4_PCOS_BROAD

241

3516

0.68

8.21

1.4

1.1

0.89

g/l

0.07

241

3509

Cervical disc disorders

516

6697

0.76

8.18

1.2

0.89

g/l

0.12

511

6678

Manic episode

658

0.28

8.07

1.4

1.1

0.94

0.89

g/l

0.39

658

Intentional self-harm by sharp object

571

0.24

7.93

1.2

1.1

0.83

0.88

g/l

0.30

571

Oedema, not elsewhere classified

393

5150

0.74

7.93

1.4

1.2

0.88

0.89

g/l

0.38

387

5136

Nonischemic cardiomyopathy

1153

0.45

7.92

1.3

1.2

0.90

0.91

g/l

0.03

1153

Asthma, hospital admissions 3, pneumonia

399

5317

0.74

7.85

1.2

0.88

0.89

g/l

0.17

399

5297

Asthma-related pneumonia or sepsis

399

5317

0.74

7.85

1.2

0.88

0.89

g/l

0.17

399

5297

Asthma-related pneumonia

398

5305

0.74

7.84

1.2

0.88

0.89

g/l

0.16

398

5285

Schizoid personality disorder

341

0.17

7.84

1.7

1.2

0.85

0.93

g/l

—

341

Malignant neoplasm of prostate

187

1702

0.65

7.80

1.4

1.3

0.88

0.87

g/l

0.19

187

1688

Disorders of the thyroid gland

1858

13812

0.87

7.77

1.2

0.89

0.88

g/l

0.94

1853

13764

Gonarthrosis, primary, with knee surgery

501

5059

0.77

7.73

1.3

0.91

0.89

g/l

0.87

496

5030

Biliary cirrhosis, secondary

21.45

7.67

3.3

1.0

0.74

0.87

g/l

—

Symptoms and signs involving the circulatory and respiratory systems

2585

14550

0.89

7.60

1.2

1.1

0.88

0.89

g/l

1.34

2578

14512

Agoraphobia

925

0.41

7.57

1.5

1.1

0.90

0.88

g/l

0.16

925

Hypothyroidism, strict autoimmune, 3 medication purchases required

1558

12111

0.86

7.49

1.2

0.88

g/l

0.52

1553

12072

Codeine

2336

14227

0.88

7.39

1.2

1.1

0.90

0.88

g/l

1.69

2324

14201

Caries of dentine, including avohilmo

1586

9370

0.86

7.26

1.2

0.89

g/l

0.08

1581

9343

Hallux valgus (acquired)

459

4263

0.76

7.20

1.2

0.87

0.89

g/l

1.53

453

4250

Neoplasms

2251

13313

0.88

7.19

1.2

1.1

0.89

0.88

g/l

0.44

2245

13276

Meniscus derangement

1073

8448

0.84

7.14

1.2

0.90

g/l

0.12

1064

8426

Disorders of synovium and tendon

1147

11450

0.84

7.13

1.1

1.2

0.88

0.89

g/l

0.29

1141

11425

Gender identity disorders

298

0.16

7.02

1.0

1.1

1.06

0.85

g/l

—

298

Benign neoplasms

2454

14959

0.89

7.02

1.2

1.1

0.88

0.89

g/l

0.63

2448

14911

Arthropathies

2383

13508

0.89

6.92

1.2

1.1

0.89

0.88

g/l

0.53

2375

13477

Coxarthrosis, primary

526

5536

0.78

6.83

1.3

0.91

0.89

g/l

0.61

521

5504

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

848

10168

0.83

6.78

1.3

1.2

0.88

g/l

0.02

842

10133

Diseases of the skin and subcutaneous tissue

2378

13365

0.89

6.72

1.2

1.1

0.88

0.89

g/l

0.38

2373

13325

severe traumatic brain injury, does not include concussion

160

2435

0.65

6.72

1.3

1.2

0.84

0.89

g/l

2.06

160

2425

Diseases of the ear and mastoid process

2854

15859

0.90

6.70

1.2

1.1

0.88

0.89

g/l

0.27

2846

15811

Congenital malformations of gallbladder, bile ducts and liver

3.16

6.65

3.7

1.2

0.87

0.91

g/l

0.29

Atopic dermatitis

1997

14095

1.13

6.56

1.1

0.87

0.89

g/l

1.75

1991

14064

Conjunctivitis

2168

15554

1.13

6.45

1.1

0.87

0.89

g/l

2.81

2163

15514

Dermatitis

1101

12591

0.85

6.40

1.2

0.89

0.88

g/l

0.16

1096

12544

Covid-19 suspected case

410

5286

0.77

6.39

1.2

1.1

0.88

g/l

0.11

410

5276

Methotrexate

139

2144

0.64

6.31

1.1

1.2

0.84

0.89

g/l

1.88

139

2139

Other disorders of urethra and urinary system

1143

9279

0.85

6.26

1.2

0.87

0.88

g/l

0.16

1137

9245

Open wound of head

989

10927

0.84

6.21

1.2

0.90

0.89

g/l

0.08

984

10893

Artificial joint operation, meniscal resection

1624

11813

0.87

6.16

1.2

0.89

0.90

g/l

0.30

1615

11770

Assault by sharp object

437

0.24

6.13

2.2

1.2

0.96

0.92

g/l

0.21

437

Other and unspecified nerve root and plexus disorders, also in other diseases

333

4383

0.75

6.08

1.1

1.2

0.91

0.89

g/l

0.68

333

4373

Other external causes of accidental injury

1954

11004

0.89

5.94

1.2

1.1

0.88

g/l

0.07

1948

10973

Codeine or tramadol medication

2641

15849

0.90

5.93

1.2

0.89

0.88

g/l

1.19

2625

15807

Non-small cell lung cancer, including Hilmo

797

0.46

5.88

1.8

1.3

0.95

0.88

g/l

0.75

790

2490

13990

0.90

5.87

1.2

1.1

0.89

0.88

g/l

0.11

2482

13941

Hypothyreosis and Thyroxine purchase for inclusion criteria

1784

13143

0.88

5.72

1.2

0.89

0.88

g/l

0.72

1779

13098

Soft tissue disorders related to use, overuse and pressure

384

4925

0.77

5.72

1.2

0.91

0.90

g/l

0.40

379

4915

Symptoms and signs involving the digestive system and abdomen

2419

13435

0.90

5.71

1.2

1.1

0.90

0.88

g/l

2.26

2412

13394

Seropositive rheumatoid arthritis

250

3381

0.73

5.68

1.1

1.2

0.83

0.89

g/l

4.32

250

3370

Cardiac arrest

669

0.45

5.57

1.4

1.2

0.76

0.91

g/l

2.61

669

Dental caries, including avohilmo

1443

8420

0.87

5.53

1.2

0.89

g/l

0.01

1438

8395

Diabetic maculopathy

1196

0.57

5.46

1.2

1.3

0.74

0.84

g/l

2.46

1186

Accidents

1966

11004

0.89

5.42

1.2

1.1

0.88

g/l

0.14

1960

10973

Cough

665

7457

0.83

5.40

1.2

0.89

g/l

0.19

660

7433

Myocardial infarction, unclassifiable

942

0.54

5.27

1.3

0.81

0.89

g/l

1.16

936

Transient ischemic attack

442

4401

0.80

5.20

1.3

0.83

0.90

g/l

5.84

435

4383

Cystic disease of liver

3.07

5.18

4.0

1.2

0.89

0.90

g/l

0.05

Abdominal and pelvic pain

2429

13435

0.90

5.13

1.2

1.1

0.90

0.88

g/l

1.40

2422

13394

Disorders of conjunctiva

2287

16061

1.11

5.05

1.2

0.87

0.89

g/l

2.39

2282

16012

Human immunodeficiency virus [HIV] disease, including avohilmo

460

0.33

4.97

1.1

1.2

0.89

0.92

g/l

0.09

460

Follow-up examination after treatment for conditions other than malignant neoplasms

971

7486

0.86

4.93

1.2

1.1

0.89

0.88

g/l

0.35

971

7460

Other and unspecified degenerative diseases of nervous system

125

0.00

4.93

0.0

1.3

—

0.90

—

125

Human immunodeficiency virus [HIV] disease

457

0.34

4.91

1.1

1.2

0.89

0.92

g/l

0.09

457

Chronic lower respiratory diseases

2875

16500

0.91

4.89

1.2

0.88

0.89

g/l

1.20

2869

16443

Dependent personality disorder

305

0.29

4.87

1.9

1.2

0.98

0.90

g/l

—

305

Other symptoms and signs involving general sensations and perceptions

491

0.36

4.84

1.4

1.2

1.03

0.90

g/l

0.80

491

Conduct disorder

540

0.39

4.80

1.1

0.85

0.88

g/l

0.59

540

Other diseases of biliary tract

125

830

1.52

4.75

2.8

1.2

0.89

g/l

0.14

125

830

Algoneurodystrophy

637

0.44

4.73

1.1

0.90

0.89

g/l

0.13

637

First line medication for Crohn's disease

2698

15833

0.91

4.73

1.3

1.1

0.88

0.89

g/l

0.44

2692

15785

Assault by bodily force

161

2261

0.70

4.72

1.1

0.90

g/l

0.06

161

2256

Other shoulder lesions

144

2067

0.69

4.72

1.1

1.2

0.93

0.90

g/l

0.88

144

2067

Anxious personality disorder

477

0.36

4.69

1.1

0.86

0.88

g/l

0.26

477

Gingivitis and periodontal diseases

2238

12714

0.91

4.67

1.2

1.1

0.89

g/l

0.43

2233

12674

ILD medications

2725

15999

0.91

4.64

1.3

1.1

0.88

0.89

g/l

0.47

2718

15949

Injuries to the shoulder and upper arm

1761

15077

0.90

4.63

1.2

0.89

g/l

0.04

1751

15027

Other diseases of blood and blood-forming organs, wide

242

3198

0.75

4.63

1.4

1.2

0.89

g/l

0.00

242

3189

Fall on and from stairs and steps

362

4537

0.79

4.55

1.2

0.88

0.89

g/l

0.31

357

4525

Behavioural disorders

526

0.40

4.52

1.1

0.85

0.88

g/l

0.57

526

539

0.41

4.48

1.3

1.2

0.91

g/l

0.04

539

Implicit viral Sepsis, including avohilmo

342

4299

0.79

4.48

1.7

1.2

0.87

0.89

g/l

0.39

336

4285

Other and unspecified mental retardation

224

0.21

4.48

1.0

1.2

0.95

0.91

g/l

—

224

Poisoning by narcotics and psychodysleptics [hallucinogens]

392

0.32

4.47

1.1

0.82

0.91

g/l

0.54

392

Other/unspecified seropositive rheumatoid arthritis

245

3204

0.76

4.35

1.1

1.2

0.83

0.89

g/l

4.24

245

3196

Biological medication for rheuma

368

4565

0.80

4.32

1.1

0.88

0.89

g/l

0.33

368

4557

Seropositive rheumatoid arthritis, wide

250

3257

0.76

4.32

1.1

1.2

0.83

0.89

g/l

4.34

250

3249

Human immunodeficiency virus [HIV] disease resulting in other conditions

427

0.36

4.30

1.1

1.2

0.89

0.92

g/l

0.09

427

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

427

0.36

4.30

1.1

1.2

0.89

0.92

g/l

0.09

427

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

244

3185

0.76

4.28

1.1

1.2

0.83

0.89

g/l

4.16

244

3177

Abnormalities of heart beat

581

6691

0.84

4.26

1.2

1.1

0.88

0.89

g/l

0.35

575

6672

Tumor necrosis factor alpha inhibitors

330

4130

0.79

4.22

1.1

0.88

0.89

g/l

0.64

330

4122

Cytomegaloviral disease, including avohilmo

375

1.76

4.20

2.8

1.2

0.93

0.90

g/l

0.63

375

Poisoning by medicine, drug-induced

247

0.27

4.13

1.0

1.2

1.00

0.92

g/l

—

247

Moderate mental retardation

104

0.00

4.13

0.0

1.2

—

0.91

—

104

Seropositive rheumatoid arthritis, strict definition

144

2018

0.71

4.11

1.1

1.2

0.83

0.89

g/l

3.08

144

2013

Glucagon-like peptide-1 (GLP-1) analogues

562

6654

0.84

4.04

1.3

1.2

0.84

0.90

g/l

5.05

556

6644

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

562

6654

0.84

4.04

1.3

1.2

0.84

0.90

g/l

5.05

556

6644

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

116

1683

0.68

4.02

1.4

1.2

0.89

g/l

0.06

116

1676

Diabetic neuropathy

886

0.57

4.02

1.8

1.3

0.89

0.83

g/l

0.55

876

Fibrosis of liver

2.76

3.99

2.6

1.1

0.86

0.92

g/l

0.38

Urticaria and erythema

686

7982

0.85

3.98

1.1

1.2

0.89

0.88

g/l

0.47

681

7963

Brain glioblastoma and astrocytoma

243

0.28

3.93

1.3

1.2

0.77

0.91

g/l

—

243

Charcot foot

259

0.30

3.91

1.5

1.2

0.80

0.93

g/l

—

259

Paranoid personality disorder

322

0.30

3.91

1.3

1.1

0.97

0.90

g/l

—

322

Hypermobility syndrome

1269

0.64

3.89

1.1

0.87

g/l

0.12

1269

ILD medications: prednisolone, methylprednisolone, prednisone

2597

15623

0.92

3.89

1.4

1.1

0.88

0.89

g/l

0.49

2590

15574

Alcohol abuse counselling and surveillance

320

0.30

3.88

2.3

1.2

0.99

0.90

g/l

—

320

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

252

0.30

3.87

1.0

1.1

1.01

0.92

g/l

—

252

Arthropathies in other diseases classified elsewhere

549

0.46

3.85

1.3

1.1

0.86

0.90

g/l

0.24

549

Other extrapyramidal and movement disorders in other diseases

271

3438

0.78

3.85

1.3

1.2

0.90

0.89

g/l

0.33

271

3428

Sulfasalazine

483

5769

0.83

3.85

1.2

0.86

0.89

g/l

3.22

483

5756

Hypertension, portal

3.82

3.75

3.3

1.2

0.83

g/l

0.00

Unspecified human immunodeficiency virus [HIV] disease

234

0.29

3.74

1.0

1.1

1.02

0.92

g/l

—

234

Urticaria

571

6701

0.85

3.73

1.1

0.89

0.88

g/l

0.96

566

6686

Blood alcohol or alcohol intoxication level

499

0.45

3.73

1.0

1.2

0.91

0.90

g/l

0.06

499

Pervasive developmental disorders excl. Autism + Asperger

216

0.27

3.71

1.5

1.1

0.84

0.87

g/l

—

216

Use of pramipexole

192

2531

0.75

3.69

1.3

1.2

0.89

0.90

g/l

0.21

192

2524

Symptoms and signs involving the skin and subcutaneous tissue

1406

14690

0.90

3.67

1.2

0.88

g/l

0.78

1398

14642

Premature rupture of membranes

549

4593

0.84

3.63

1.1

0.86

g/l

0.30

549

4584

Hyperfunction of pituitary gland

1005

0.62

3.60

1.2

1.1

0.84

0.87

g/l

0.77

1005

Cerebral palsy

336

0.35

3.59

1.2

1.1

0.83

0.90

g/l

0.92

336

Cytomegaloviral disease

363

1.70

3.56

2.9

1.2

0.93

0.90

g/l

0.50

363

Kela-code for behavioural disturbances in mental retardation

0.00

3.56

0.0

1.1

—

0.89

—

Malignant neoplasm of urinary organs, including Hilmo

884

0.60

3.55

1.5

1.2

0.94

0.90

g/l

0.73

878

Other dialysis

407

0.41

3.52

2.4

1.2

0.94

0.91

g/l

0.19

407

Inflammatory disease of uterus

253

3182

0.79

3.45

1.2

1.1

0.88

0.86

g/l

0.61

253

3177

Dislocation, sprain and strain of joints and ligaments of knee

1857

15402

1.09

3.42

1.2

1.1

0.89

g/l

0.87

1850

15363

Exposure to unspecified factor

2340

17173

0.92

3.41

1.2

0.90

0.88

g/l

1.49

2328

17121

Adrenocortical insufficiency

536

0.49

3.39

2.3

1.2

0.88

0.89

g/l

0.18

536

False labour

829

5840

0.87

3.36

1.1

0.86

0.87

g/l

0.34

829

5829

Myocardial infarction, without ST-elevation

246

2797

0.79

3.31

1.4

1.3

0.79

0.89

g/l

7.51

240

2782

Fibroblastic disorders

260

3246

0.80

3.28

1.2

0.89

g/l

0.04

253

3239

Fibrosis and sclerosis of liver

6.13

3.27

3.4

1.3

0.92

0.80

g/l

—

Cytomegalovirus infection, IBD co-morbidity

327

1.69

3.22

3.1

1.1

0.94

0.90

g/l

0.73

327

Parkinson's disease, excluding more controls

838

0.62

3.21

1.3

0.82

0.89

g/l

1.94

833

Diseases of appendix

2005

16549

1.09

3.18

1.2

0.89

g/l

0.56

1996

16501

Sleep disorders, other/unspecified

802

0.60

3.18

1.4

1.2

0.89

0.88

g/l

0.06

802

Cholecystectomy

1166

10973

0.90

3.16

1.2

0.89

0.88

g/l

0.61

1160

10934

358

0.41

3.15

1.1

0.89

0.83

g/l

0.60

358

Previous suicide attempt

216

0.31

3.14

1.1

0.74

0.88

g/l

—

216

Panhypopituitarism

231

0.34

3.10

1.3

1.1

0.89

g/l

—

231

Habit and impulse disorders

408

0.45

3.09

1.0

1.1

0.95

0.91

g/l

0.29

408

Iridocyclitis

342

4116

0.83

3.06

1.2

0.88

0.89

g/l

0.41

342

4104

Intentional self-harm by unspecified means

280

0.35

3.05

1.0

1.1

0.73

0.87

g/l

—

280

Other general symptoms and signs

1051

0.66

3.04

1.2

1.1

0.98

0.88

g/l

1.63

1051

Assault by other specified means

239

0.36

3.03

1.0

1.1

0.89

0.90

g/l

—

239

Anorexia (incl.atypical)

1271

0.69

3.02

1.1

0.80

0.85

g/l

2.14

1271

Generalized epilepsy

840

0.62

3.01

1.1

0.86

0.89

g/l

0.34

840

Appendicitis, broad definition

1991

16535

1.08

2.99

1.2

0.89

g/l

0.59

1982

16487

Late syphilis, including avohilmo

225

0.35

2.98

1.5

1.2

1.05

0.91

g/l

—

225

Pre-eclampsia or poor fetal growth

677

7661

0.87

2.96

1.1

0.88

0.86

g/l

0.58

677

7647

Use of interferon beta-1a

533

0.53

2.96

1.1

0.86

0.89

g/l

0.36

533

6-mercaptopurine

870

0.63

2.94

1.3

1.2

0.87

0.89

g/l

0.40

870

Immunodeficiencies

738

0.60

2.94

1.4

1.2

0.89

g/l

0.05

738

Atrial septal defect, secundum type

388

0.45

2.94

1.1

1.2

0.90

0.89

g/l

0.02

388

Adenocarcinoma and ductal carcinoma of pancreas

223

0.36

2.93

1.1

1.2

0.97

0.90

g/l

—

223

Sequelae of injuries of neck and trunk

482

0.51

2.93

1.3

1.2

0.84

0.92

g/l

0.92

482

Hyperprolactinaemia

759

0.61

2.92

1.2

1.1

0.82

0.88

g/l

1.13

759

Disease of hard tissues of teeth, NOS

1118

6488

0.90

2.92

1.2

1.1

0.90

0.89

g/l

0.24

1113

6469

Open wound of abdomen, lower back and pelvis

622

0.57

2.92

1.2

0.91

0.90

g/l

0.08

622

Evidence of alcohol involvement determined by level of intoxication

222

0.35

2.88

1.0

1.1

1.01

0.92

g/l

—

222

Radial styloid tenosynovitis [de Quervain]

1293

0.70

2.86

1.2

1.1

0.84

0.89

g/l

1.31

1293

Enduring personality changes

0.00

2.86

0.0

1.1

—

0.88

—

Paracetamol or NSAID medication

431

1835

1.19

2.85

1.1

0.89

0.88

g/l

0.51

431

1829

Adenocarcinoma of pancreas

172

0.29

2.84

1.2

1.06

0.90

g/l

—

172

Toxic effect of ethanol

851

0.63

2.84

1.2

0.91

0.89

g/l

0.19

851

Other joint disorders

2418

13497

0.93

2.80

1.2

1.1

0.89

0.88

g/l

0.72

2409

13466

Allergic contact dermatitis

227

2811

0.80

2.77

1.1

1.2

0.89

g/l

0.15

227

2806

Later onset COPD

425

0.55

2.74

1.3

1.6

0.95

0.86

g/l

0.81

415

Injury of nerves and spinal cord at neck level

281

0.38

2.73

1.1

1.02

0.92

g/l

0.24

281

Causalgia

293

0.40

2.71

1.0

1.2

0.91

g/l

0.04

293

Other disorders of adrenal gland

684

0.61

2.70

1.9

1.2

0.87

0.89

g/l

0.17

684

Pustulosis palmaris et plantaris

633

0.59

2.68

1.1

1.2

0.91

0.89

g/l

0.14

633

Migraine without aura

519

5953

0.87

2.66

1.1

0.87

g/l

0.06

519

5941

Hidradenitis suppurativa

905

0.66

2.61

1.0

1.1

0.86

0.88

g/l

0.32

905

Myocarditis

1036

0.68

2.60

1.2

1.1

0.92

0.91

g/l

0.09

1036

Somnolence, stupor and coma

552

0.57

2.58

1.5

1.2

0.79

0.90

g/l

1.95

552

Acute and subacute iridocyclitis

292

3496

0.83

2.55

1.2

0.88

0.89

g/l

0.36

292

3489

Monoarthritis, not elsewhere classified

722

0.63

2.55

1.2

1.1

0.86

0.90

g/l

0.53

722

Unspecified event, undetermined intent

458

0.53

2.54

1.2

0.93

0.91

g/l

0.14

458

Open wound of thorax

297

0.43

2.53

1.2

1.1

1.04

0.93

g/l

0.57

297

Neuralgia and neuritis, unspecified

948

0.68

2.52

1.3

1.2

0.89

0.90

g/l

0.16

948

Cardiomyopathy, other and unspecified

925

0.68

2.50

1.3

1.2

0.93

0.90

g/l

0.46

925

Polyarthritis, unspecified

520

0.57

2.48

1.3

1.2

0.87

0.90

g/l

0.29

520

Disorders of lacrimal system

681

7524

0.89

2.48

1.2

0.87

0.89

g/l

0.64

676

7498

Other and unspecified iridocyclitis

801

0.65

2.47

1.1

1.2

0.87

0.89

g/l

0.27

801

Congenital absence of the uterus

4.63

2.46

1.0

0.73

0.77

g/l

—

Acidosis

189

0.37

2.43

1.6

1.2

0.65

0.91

g/l

—

189

Later onset COPD, excluding more controls

388

0.57

2.42

1.3

1.6

0.95

0.87

g/l

0.67

377

Pustular psoriasis

688

0.63

2.41

1.1

1.2

0.90

0.89

g/l

0.11

688

Disorders of synovium and tendon in diseases classified elsewhere

345

0.48

2.39

1.3

1.2

0.93

0.90

g/l

0.30

345

Ehlers-Danlos syndrome

216

0.40

2.39

1.0

1.1

0.77

0.87

g/l

—

216

Acute laryngitis and tracheitis

300

3498

0.84

2.39

1.1

0.88

0.89

g/l

0.01

300

3493

Imperforate hymen

3.86

2.37

1.0

0.88

0.80

g/l

—

Disorders resulting from impaired renal tubular function

448

0.55

2.35

1.8

1.2

0.99

0.91

g/l

0.35

448

Other/unspecified cytomegaloviral diseases

262

1.64

2.32

3.3

1.1

0.96

0.91

g/l

0.72

262

Other and unspecified follicular disorders

776

0.66

2.31

1.2

0.88

0.89

g/l

0.19

776

Other lack of coordination

169

0.35

2.31

1.0

1.1

0.85

0.90

g/l

—

169

Endocarditis

380

0.52

2.28

1.3

1.2

0.99

0.91

g/l

0.54

380

Superficial injury of hip and thigh

153

1933

0.79

2.28

1.3

1.2

0.85

0.88

g/l

1.25

153

1928

Spontaneous rupture of synovium and tendon

1173

0.73

2.27

1.2

0.89

0.90

g/l

0.19

1173

Cramp and spasm

797

0.67

2.27

1.1

1.2

0.90

0.89

g/l

0.08

797

Other congenital malformations of female genitalia

158

1.84

2.25

1.0

1.1

0.85

0.81

g/l

0.39

158

Prolonged pregnancy

420

4110

0.86

2.21

1.1

0.84

0.86

g/l

1.40

420

4103

Drug-induced obesity

167

0.35

2.20

1.0

1.1

0.80

0.88

g/l

—

167

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

239

0.41

2.19

1.3

1.2

0.80

0.90

g/l

—

239

Use of glatiramer acetate

396

0.54

2.18

1.1

0.94

0.89

g/l

0.59

396

Assault by blunt object

357

0.52

2.18

1.2

1.1

0.88

0.92

g/l

0.33

357

Poor fetal growth

300

3518

0.84

2.16

1.1

0.86

g/l

0.27

300

3513

Other leukaemias of specified cell type

3.40

2.15

2.0

1.3

0.88

0.92

g/l

—

Bronchitis

2518

15963

0.94

2.10

1.2

1.1

0.89

0.88

g/l

0.09

2508

15913

Congenital malformations of the musculoskeletal system, not elsewhere classified

288

0.47

2.10

1.1

1.2

0.84

0.89

g/l

0.57

288

Alcoholic cardiomyopathy

0.00

2.10

0.0

1.2

—

0.93

—

Meningitis

865

0.70

2.09

1.1

1.2

0.86

0.90

g/l

0.77

865

Other specified/unspecified systemic involvement of connective tissue

831

0.69

2.09

1.3

1.2

0.83

0.89

g/l

1.15

831

Bicipital tendinitis

853

0.69

2.09

1.1

1.2

0.87

0.91

g/l

0.47

853

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1301

11619

1.08

2.08

1.2

0.89

g/l

0.09

1296

11580

Fetus and newborn affected by other complications of labour and delivery

4.21

2.07

1.2

1.1

0.86

0.76

g/l

—

Diseases of the respiratory system

1548

8333

0.93

2.07

1.2

1.1

0.88

g/l

0.30

1543

8304

Late syphilis

178

0.38

2.06

1.6

1.2

1.07

0.90

g/l

—

178

Viral pneumonia

171

2105

0.81

2.06

1.3

1.2

0.89

g/l

0.05

171

2100

Communicating hydrocephalus

175

0.39

2.05

1.1

1.2

0.84

0.90

g/l

—

175

Hyperkinetic disorders (excl. ADHD)

445

0.58

2.05

1.1

0.89

0.88

g/l

0.10

445

Generalized epilepsy, mode (most common among epilepsy diagnosis)

587

0.64

2.04

1.1

1.2

0.86

0.89

g/l

0.42

587

Abnormal findings on antenatal screening of mother

204

2458

0.82

2.04

1.1

0.87

0.84

g/l

1.21

204

2453

Discitis, unspecified

163

0.36

2.03

1.0

1.3

0.84

0.90

g/l

—

163

Toxic effect of other and unspecified substances

269

0.47

2.00

1.1

0.92

0.90

g/l

0.11

269

Sleep apnoea

2122

14171

0.94

1.97

1.2

0.90

g/l

0.15

2108

14134

Anterior Iridocyclitis

311

3611

0.86

1.97

1.2

0.88

0.89

g/l

0.58

311

3604

Congenital malformation of biliary tract

3.92

1.96

2.2

1.3

0.68

0.97

g/l

—

Dementia in other diseases classified elsewhere

243

0.45

1.96

1.3

1.2

0.75

0.91

g/l

1.67

243

Carcinoma in situ of skin of upper limb, including shoulder

2.00

1.96

2.1

1.4

0.93

g/l

0.01

Congenital iodine-deficiency syndrome/hypothyroidism

295

0.50

1.95

1.1

1.2

0.83

0.90

g/l

0.39

295

Non-small cell lung cancer, adenocarcinoma, helper endpoint

295

0.51

1.93

1.7

1.3

0.99

0.90

g/l

0.60

295

Pre-eclampsia

391

4455

0.87

1.92

1.1

0.89

0.87

g/l

0.88

391

4448

Malignant neoplasm of rectosigmoid junction, including Hilmo

170

0.41

1.92

1.6

1.2

0.86

0.89

g/l

—

170

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

239

0.45

1.91

1.6

1.1

0.77

0.90

g/l

1.04

239

Use of fingolimod

249

0.46

1.91

1.0

1.1

0.90

0.89

g/l

0.08

249

Endocrine disorders, other/unspecified

278

0.49

1.90

1.4

1.1

0.79

0.90

g/l

1.39

278

Viral encephalitis, not elsewhere classified/unspecified

238

0.45

1.89

1.6

1.1

0.77

0.90

g/l

1.03

238

Calcific tendinitis of shoulder

1109

0.75

1.86

1.2

0.81

0.91

g/l

3.47

1109

Disorder of the sleep-wake schedule

339

0.55

1.85

1.5

1.1

0.85

0.90

g/l

0.35

339

Relapsing polychondritis

2.93

1.84

1.0

1.2

0.79

0.81

g/l

—

Ventricular septal defect, a heart condition

299

0.52

1.82

1.0

1.1

0.81

0.86

g/l

0.40

299

Abnormal blood-pressure reading, without diagnosis

771

0.71

1.80

1.1

1.2

0.89

0.90

g/l

0.11

771

Medial epicondylitis

804

0.71

1.80

1.3

1.2

0.93

0.91

g/l

0.27

804

Diabetes insipidus

135

0.36

1.79

1.0

1.1

1.11

0.91

g/l

—

135

Other diseases of pericardium

510

0.64

1.78

1.3

1.2

0.94

0.91

g/l

0.36

510

Metabolic disorder, other/unspecified

2.63

1.78

2.7

1.3

1.07

0.89

g/l

—

Congenital ichthyosis

0.00

1.75

0.0

1.1

—

0.91

—

Drug-induced dystonia

0.00

1.75

0.0

1.1

—

0.85

—

Use of riluzole

0.00

1.74

0.0

1.2

—

0.92

—

Enterobiasis, including avohilmo

510

1.38

1.74

1.1

0.90

0.85

g/l

0.73

510

Pre-eclampsia or eclampsia

412

4643

0.88

1.73

1.2

1.1

0.89

0.87

g/l

1.03

412

4636

Congenital malposition of the kidney

3.51

1.73

1.2

0.77

0.87

g/l

—

Idiopathic urticaria

431

0.62

1.73

1.1

0.88

0.87

g/l

0.06

431

Other demyelinating diseases of the central nervous system

843

0.72

1.73

1.2

1.1

0.89

0.90

g/l

0.10

843

Malignant neoplasm of other and ill-defined digestive organs

0.00

1.72

0.0

1.3

—

0.90

—

Carcinoma in situ of skin of scalp and neck

2.07

1.70

2.4

1.5

0.91

0.90

g/l

0.09

Viral conjunctivitis

441

0.62

1.70

1.1

0.85

0.90

g/l

0.52

441

Toxic encephalopathy

3.33

1.69

4.3

1.4

0.90

0.98

g/l

—

Muscle strain

690

0.70

1.69

1.1

1.2

0.95

0.90

g/l

0.60

690

Hypersomnia

226

0.48

1.69

1.1

1.2

0.82

0.90

g/l

0.56

226

Acute upper respiratory infections

2517

14349

1.05

1.68

1.2

0.89

0.88

g/l

0.08

2512

14296

Cytomegaloviral hepatitis

2.53

1.67

2.3

1.1

0.89

0.88

g/l

—

Disturbances of smell and taste

561

0.67

1.67

1.1

1.2

0.89

0.90

g/l

0.10

561

Bullous disorders

514

0.66

1.67

1.3

1.2

0.87

0.89

g/l

0.15

514

Tic and related disorders

238

0.49

1.67

1.1

0.84

0.87

g/l

0.21

238

Acute upper respiratory infections of multiple and unspecified sites

2043

14116

1.06

1.66

1.2

1.1

0.89

0.88

g/l

0.10

2038

14072

Nystagmus and other irregular eye movements

210

0.47

1.63

1.1

0.96

0.89

g/l

—

210

Drug-induced osteoporosis with pathological fracture

128

1.75

1.62

3.5

1.2

0.87

0.90

g/l

0.20

128

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

381

1.43

1.61

1.0

1.1

0.95

0.93

g/l

0.20

381

Assault by unspecified means

541

0.67

1.61

1.2

0.90

0.91

g/l

0.08

541

Obstructed labour due to malposition and malpresentation of fetus

719

6105

1.10

1.60

1.1

0.87

g/l

0.41

719

6092

Paraplegia, diplegia of upper limbs

261

0.53

1.60

1.4

1.1

0.94

0.91

g/l

0.13

261

Viral pneumonia (known virus, not influenza)

287

0.55

1.59

1.9

1.2

0.83

0.89

g/l

0.38

287

Juvenile arthritis (FINNGEN)

1024

0.76

1.59

1.3

1.1

0.82

0.87

g/l

1.41

1024

Acute appendicitis

1864

16384

1.06

1.59

1.2

0.89

g/l

0.50

1856

16336

Unspecified jaundice

482

1.36

1.58

2.5

1.2

0.91

0.89

g/l

0.43

482

Asymptomatic human immunodeficiency virus [HIV] infection status

144

0.40

1.58

1.2

1.1

0.78

0.90

g/l

—

144

Type 1 diabetes, strict definition, subgroup 2

0.00

1.57

0.0

1.1

—

0.91

—

Diseases of thymus

0.00

1.57

0.0

1.2

—

0.91

—

Placental disorders

218

0.49

1.56

1.0

1.1

0.92

0.84

g/l

0.42

218

Prurigo nodularis

259

0.53

1.56

1.3

1.2

0.98

0.94

g/l

0.31

259

Disorders of skin appendages

1142

12144

0.93

1.55

1.2

1.1

0.88

g/l

0.54

1137

12119

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

576

0.69

1.55

1.5

1.2

0.92

0.89

g/l

0.31

576

Toxic liver disease

193

1.58

1.54

1.9

1.1

0.94

0.90

g/l

0.36

193

Other diseases of urinary system

2084

12305

0.95

1.54

1.2

0.87

0.88

g/l

2.10

2075

12264

Lichen simplex chronicus

502

0.67

1.53

1.0

1.2

0.94

0.91

g/l

0.28

502

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

368

0.61

1.53

1.1

1.2

0.86

0.87

g/l

0.09

368

SLE (Finngen)

537

0.68

1.52

1.1

1.2

0.82

0.89

g/l

0.92

537

547

0.68

1.52

1.3

1.1

0.84

0.85

g/l

0.05

547

Isolated proteinuria with specified morphological lesion

126

0.39

1.52

2.0

1.1

0.88

0.91

g/l

—

126

Other/unspecified synovitis and tenosynovitis

182

2150

0.84

1.52

1.2

0.87

0.89

g/l

0.63

182

2150

Anosmia

376

0.63

1.52

1.2

1.1

0.88

0.92

g/l

0.40

376

Congenital malformations of uterus and cervix

471

1.36

1.51

1.1

0.84

g/l

0.04

471

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

126

0.39

1.51

1.2

1.07

0.90

g/l

—

126

Amblyopia ex anopsia

641

0.71

1.51

1.2

1.1

0.88

g/l

0.01

641

Other mosquito-borne viral fevers, including avohilmo

132

1.72

1.51

1.0

1.1

0.90

g/l

0.03

132

Carrier of infectious disease

380

0.62

1.51

1.5

1.1

0.77

0.88

g/l

1.84

380

Other epidermal thickening

571

0.69

1.50

1.4

1.2

0.86

0.90

g/l

0.44

571

Complications of genitourinary prosthetic devices, implants and grafts

343

0.60

1.50

1.1

1.2

0.93

0.89

g/l

0.46

343

Other specified and unspecified disorders of choroid

2.31

1.50

1.3

1.2

0.95

0.85

g/l

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

206

2389

0.85

1.49

1.2

1.1

0.88

0.87

g/l

0.24

206

2384

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

376

4214

0.89

1.49

1.1

0.85

0.86

g/l

0.35

376

4208

Other and unspecified hydrocephalus

170

0.46

1.48

1.4

1.1

0.85

0.90

g/l

—

170

Accidental poisoning by and exposure to alcohol

316

0.59

1.47

1.0

1.1

0.90

0.88

g/l

0.12

316

Cushing syndrome

151

0.45

1.46

1.0

1.2

1.12

0.91

g/l

—

151

Sleep disorders (combined)

2795

13976

1.05

1.46

1.2

0.89

g/l

0.09

2786

13942

Allergic contact dermatitis due to drugs in contact with skin

278

0.57

1.46

1.4

1.2

0.93

0.90

g/l

0.19

278

Certolizumab pegol

387

0.63

1.45

1.0

1.1

0.86

0.87

g/l

0.08

387

Alopecia universalis

2.29

1.45

1.2

1.1

0.85

0.84

g/l

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1157

11265

0.94

1.42

1.2

1.1

0.87

0.88

g/l

1.31

1151

11248

SLE, strict definition

493

0.68

1.41

1.1

1.2

0.81

0.88

g/l

0.93

493

SLE, ICD10

493

0.68

1.41

1.1

1.2

0.81

0.88

g/l

0.93

493

Genitourinary diseases

1645

8712

0.94

1.41

1.2

1.1

0.88

0.90

g/l

1.76

1640

8688

Erythema nodosum

433

0.66

1.40

1.2

0.90

0.88

g/l

0.15

433

Symptoms and signs involving emotional state

573

0.71

1.40

1.0

1.2

0.89

g/l

0.06

573

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

688

0.73

1.40

1.2

0.89

g/l

0.11

688

Fetal death of unspecified cause

0.00

1.40

0.0

1.1

—

0.88

—

Other and unspecified coagulation defects

948

0.77

1.39

1.1

1.2

0.90

0.88

g/l

0.22

948

Other acute disseminated demyelination

209

0.51

1.39

1.3

1.2

0.81

0.89

g/l

0.87

209

Supervision of normal pregnancy

715

3758

1.09

1.39

1.1

0.86

0.87

g/l

0.32

715

3750

Congenital absence, atresia and stenosis of large intestine

3.13

1.39

1.2

1.0

0.84

0.88

g/l

—

Hypothyroidism due to medicaments and other exogenous substances

124

0.40

1.38

1.0

1.1

0.86

0.90

g/l

—

124

Marasmic kwashiorkor

3.05

1.38

1.0

1.1

0.63

0.77

g/l

—

Obstructive hydrocephalus

161

0.49

1.38

1.3

1.1

0.78

0.92

g/l

—

161

Exposure to other specified electric current

535

0.70

1.37

1.2

1.1

0.86

0.90

g/l

0.68

535

Abscess of lung

164

0.48

1.37

1.0

1.1

0.92

g/l

—

164

Anomalies of pupillary function

358

0.63

1.37

1.0

1.2

0.93

0.90

g/l

0.18

358

Systemic sclerosis (FG)

334

0.62

1.37

1.1

1.2

0.92

0.89

g/l

0.23

334

Cardiomyopathy, Hypertrophic obstructive

164

0.48

1.37

1.1

1.2

1.01

0.90

g/l

—

164

Myeloid leukaemia

235

0.55

1.36

1.2

0.86

0.91

g/l

0.33

235

Oligomenorrhoea

696

0.74

1.36

1.3

1.1

0.79

0.86

g/l

1.47

696

Multiple myeloma and malignant plasma cell neoplasms

273

0.58

1.36

3.0

1.3

0.79

0.91

g/l

0.96

273

Septal defects

1044

0.79

1.35

1.1

0.81

0.88

g/l

1.64

1044

Ehlers-Danlos syndrome, including avohilmo

282

0.59

1.34

1.1

0.85

0.87

g/l

0.19

282

Crohn's disease (strict) with PSC

2.53

1.34

3.3

1.1

0.81

0.86

g/l

—

Rheumatic fever incl heart disease

221

0.54

1.34

1.2

0.92

g/l

0.04

221

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

251

1.47

1.33

1.1

1.2

0.94

0.87

g/l

1.10

251

Tonsillectomy and adenotomy

1985

13174

1.05

1.33

1.1

0.89

g/l

0.23

1979

13151

Other and unspecified parapsoriasis

0.00

1.33

0.0

1.2

—

0.86

—

Personal history of risk-factors, not elsewhere classified

244

0.56

1.32

1.2

1.1

0.81

0.89

g/l

0.58

244

Benign neoplasm: Brain, supratentorial

219

0.54

1.32

1.4

1.1

0.86

0.89

g/l

0.17

219

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

462

0.69

1.31

1.3

1.2

0.86

0.90

g/l

0.38

462

Evidence of alcohol involvement determined by blood alcohol level

268

0.59

1.31

1.0

1.1

0.84

0.90

g/l

0.61

268

Other benign neoplasms of uterus

270

0.59

1.31

1.1

1.2

0.88

0.90

g/l

0.05

270

Juvenile rheumatoid arthirtis

528

0.71

1.29

1.2

1.1

0.85

0.89

g/l

0.42

528

Social disorders starting during childhood or adolecense, excluding more controls

160

0.49

1.28

1.6

1.1

0.75

0.86

g/l

—

160

Effects of air pressure and water pressure

100

1.76

1.28

1.1

0.84

0.88

g/l

0.32

100

Female infertility, uterine origin

1.84

1.27

1.1

1.2

0.78

0.91

g/l

1.93

Dengue, including avohilmo

2.52

1.27

1.2

1.3

0.76

0.86

g/l

—

Post-traumatic wound infection, not elsewhere classified

446

0.69

1.27

1.1

1.2

0.85

0.90

g/l

1.04

446

Benign neoplasm: Heart

2.47

1.26

1.0

1.2

0.80

0.93

g/l

—

Chromosomal abnormalities, not elsewhere classified

396

0.67

1.25

1.1

0.87

0.90

g/l

0.27

396

Congenital malformations of the respiratory system, including avohilmo

240

0.57

1.25

1.0

1.2

0.83

0.90

g/l

0.81

240

Other and unspecified disorders of psychological development

195

0.54

1.24

1.1

0.84

0.89

g/l

0.42

195

Acquired stenosis of external ear canal

108

1.70

1.24

1.1

1.2

0.98

0.90

g/l

0.51

108

Disorders of parathyroid gland, other and/or unspecified

2.04

1.24

1.9

1.3

0.91

0.93

g/l

—

Other infestations

2.72

1.23

1.0

1.2

0.86

0.91

g/l

—

Other acute viral hepatitis

238

0.58

1.23

1.8

1.1

0.91

0.89

g/l

0.09

238

Systemic lupus erythematosus

512

0.72

1.22

1.1

1.2

0.82

0.88

g/l

0.80

512

Bicornuate uterus

149

1.59

1.22

1.1

1.2

0.85

0.86

g/l

0.22

149

Personal history of certain other diseases

394

0.67

1.21

1.3

1.1

0.85

g/l

0.06

394

Lifestyle-related condition

168

0.53

1.21

1.3

1.1

0.79

0.92

g/l

—

168

Aggressive periodontitis

262

0.60

1.20

1.6

1.2

0.98

0.92

g/l

0.36

262

Cerebral oedema

0.00

1.19

0.0

1.2

—

0.90

—

Synovial cyst of popliteal space [Baker]

928

0.79

1.19

1.1

1.2

0.88

0.91

g/l

0.46

928

Hypercalcemia

370

0.67

1.18

1.4

1.2

0.90

0.89

g/l

0.05

370

Ankylosing spondylitis, strict definition

1089

0.81

1.18

1.0

1.2

0.87

0.90

g/l

0.82

1089

Fluid overload

0.00

1.18

0.0

1.1

—

0.94

—

Pityriasis rubra pilaris

0.00

1.18

0.0

1.2

—

0.84

—

Secondary thrombocytopenia

130

0.45

1.17

1.8

1.2

0.89

g/l

—

130

Other disorders of white blood cells

702

0.76

1.17

1.1

1.2

0.90

0.89

g/l

0.15

702

Mucinous and mucinous cystic tumor of rectum

0.00

1.17

0.0

1.2

—

0.92

—

Acute myeloid leukaemia and myelodysplastic syndromes

127

0.47

1.17

1.3

1.2

0.79

0.90

g/l

—

127

Any event in hilmo or specialist outpatient

126

0.57

1.17

1.4

1.0

0.92

0.89

g/l

0.11

126

Heart failure and hypertrophic cardiomyopathy

130

0.46

1.16

1.0

1.2

1.07

0.91

g/l

—

130

Other and unspecified nail disorders

332

0.65

1.16

1.2

0.88

0.91

g/l

0.44

332

Other diseases of upper respiratory tract

2663

13347

1.04

1.16

1.2

0.88

0.89

g/l

0.06

2654

13297

Pericarditis

473

0.71

1.16

1.3

1.2

0.97

0.91

g/l

0.36

473

Unicornuate uterus

2.06

1.15

1.0

1.1

0.88

0.83

g/l

—

Hypocalcemia

271

0.62

1.15

1.6

1.2

0.85

0.91

g/l

0.43

271

Systemic sclerosis

319

0.65

1.15

1.1

1.2

0.92

0.90

g/l

0.15

319

Other disorders of Eustachian tube

459

0.71

1.14

1.2

0.85

0.89

g/l

0.46

459

Other meningitis

245

0.60

1.14

1.1

1.2

0.79

0.90

g/l

1.39

245

Disorders of parathyroid gland

170

1941

0.86

1.13

1.6

1.2

0.87

0.89

g/l

0.77

170

1932

Malignant neoplasm of rectosigmoid junction

113

0.44

1.13

1.2

0.84

0.89

g/l

—

113

Non-seminoma of testis, including Hilmo

165

0.53

1.13

1.6

1.1

0.98

0.93

g/l

—

165

Autoimmune thyroiditis

317

0.65

1.13

1.0

1.1

0.91

0.87

g/l

0.30

317

Other factor of the environment

182

0.54

1.12

1.3

1.1

0.81

0.90

g/l

—

182

Other and unspecified disorders of white blood cells

481

0.72

1.12

1.1

1.2

0.93

0.90

g/l

0.36

481

Keratitis

715

7658

0.93

1.12

1.2

0.89

g/l

0.00

715

7639

Lichen striatus

2.53

1.11

1.0

1.1

0.80

0.79

g/l

—

Other and unspecified epidermal thickening

364

0.68

1.11

1.4

1.2

0.87

0.90

g/l

0.31

364

Dysplastic lesion of the vulva of unknown severity

2.51

1.11

1.2

1.0

0.76

0.88

g/l

—

Inflammatory disorders of male genital organs, not elsewhere classified

194

0.56

1.11

1.1

0.93

0.91

g/l

0.07

194

Injury of muscle and tendon at forearm level

351

0.67

1.11

1.1

0.91

0.90

g/l

0.03

351

Paralytic ileus

352

0.68

1.10

1.4

1.2

0.95

0.91

g/l

0.23

352

Perichondritis of external ear

144

1.55

1.10

1.4

1.2

0.88

0.90

g/l

0.17

144

Use of levodopa decarbox-comt-inhibitor

139

0.50

1.09

1.0

1.3

0.79

0.90

g/l

—

139

Superficial injury of neck

454

0.72

1.09

1.3

1.1

0.88

0.90

g/l

0.19

454

Guttate psoriasis

242

0.61

1.09

1.3

1.1

0.87

0.90

g/l

0.21

242

Other/unspecified crystal arthropathies

2.22

1.09

2.1

1.3

0.79

0.87

g/l

—

Other and unspecified injuries of wrist and hand

792

0.79

1.08

1.2

1.1

0.89

0.88

g/l

0.19

792

Malignant neoplasm of mesothelium and soft tissue

303

0.66

1.08

1.1

1.2

0.97

0.90

g/l

0.57

303

Systemic sclerosis, icd10

314

0.66

1.08

1.1

1.2

0.92

0.90

g/l

0.15

314

Toxic effect of alcohol

337

0.67

1.07

1.3

1.1

0.89

0.91

g/l

0.18

337

Other specified/unspecified dorsopathies

545

0.75

1.07

1.2

0.87

0.90

g/l

0.39

545

Foreign body on external eye

325

3586

0.90

1.06

1.1

1.2

0.92

0.90

g/l

0.66

325

3578

Intracranial and intraspinal abscess and granuloma

123

0.48

1.06

1.2

0.75

0.91

g/l

—

123

Kyphosis

122

0.49

1.06

1.0

1.2

1.03

0.90

g/l

—

122

Secondary polycythaemia

336

0.68

1.06

1.3

1.2

0.87

0.91

g/l

0.37

336

Ovarian dysfunction: estrogen excess

2.41

1.06

1.0

1.1

0.94

0.83

g/l

—

Rheumatic valve diseases

122

0.49

1.05

1.0

1.1

1.00

0.89

g/l

—

122

Localized skin eruption due to drugs and medicaments

147

0.54

1.05

1.1

0.82

0.88

g/l

—

147

Ovarian dysfunction: androgen excess

2.38

1.05

1.0

1.1

0.88

0.83

g/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

125

0.47

1.05

2.0

1.3

0.93

0.89

g/l

—

125

Any prescribed medicine buy

2.00

1.05

1.9

1.1

0.83

0.87

g/l

—

Peritonsillar abscess

522

5635

0.92

1.04

1.1

0.89

g/l

0.18

522

5624

Disorders of orbit

665

0.78

1.03

1.3

1.2

0.94

0.89

g/l

0.57

665

Use of teriflunomide

273

0.64

1.03

1.2

1.1

0.86

0.90

g/l

0.42

273

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

107

0.46

1.03

1.0

1.1

0.92

0.88

g/l

—

107

Systemic lupus erythematosus, unspecified

438

0.72

1.02

1.1

1.2

0.81

0.89

g/l

0.84

438

Benign neoplasm: Short bones of upper limb

250

0.63

1.02

1.1

0.98

0.91

g/l

0.45

250

Iron deficiency

719

0.78

1.02

1.0

1.1

0.81

0.84

g/l

0.50

719

Accidental poisoning by and exposure to pesticides

2.09

1.02

1.3

1.2

0.86

0.85

g/l

—

Hypoplasia of dental enamel

1.93

1.02

3.1

1.1

0.76

0.85

g/l

—

Molar incisor enamel hypoplasia, with caries

1.92

1.02

3.1

1.0

0.76

0.81

g/l

—

Benign neoplasm: Bladder

1.91

1.02

1.2

0.76

0.86

g/l

—

Other bullous disorders

298

0.66

1.02

1.2

0.93

0.90

g/l

0.21

298

Exposure to smoke, fire and flames

414

0.72

1.02

1.1

0.95

0.92

g/l

0.28

414

Helminthiases, including avohilmo

783

1.21

1.01

1.2

1.1

0.90

0.87

g/l

0.54

783

Symptoms and signs involving appearance and behaviour

135

0.51

1.00

1.0

1.1

0.74

0.89

g/l

—

135

Congenital myopathies

0.00

1.00

0.0

1.1

—

0.88

—

Hyperparathyroidism

143

1635

0.86

1.00

1.5

1.2

0.87

0.90

g/l

0.86

143

1628

Other and unspecified disorders of lacrimal system

0.00

0.99

0.0

1.1

—

0.86

—

Injuries to the wrist and hand

2588

16570

1.04

0.99

1.2

0.89

0.88

g/l

1.32

2580

16516

Chondrosarcoma

0.00

0.99

0.0

1.2

—

0.79

—

Postpartum haemorrhage due to retained placenta

304

3349

0.90

0.99

1.1

0.86

0.87

g/l

0.33

304

3342

Benign neoplasm: Testis

1.91

0.99

1.0

1.2

0.90

0.91

g/l

—

Disorders in reading

353

0.70

0.98

1.0

1.1

0.95

0.88

g/l

0.64

353

Hereditary retinal dystrophy

211

0.61

0.98

1.1

1.2

0.84

0.92

g/l

0.46

211

Cauda equina syndrome

174

0.57

0.98

1.1

1.2

0.89

0.90

g/l

—

174

Malignant neoplasm, without specification of site

160

0.56

0.98

1.8

1.2

0.99

0.89

g/l

—

160

Syndrome of inappropriate secretion of antidiuretic hormone

0.00

0.98

0.0

1.2

—

0.95

—

Chronic Coagulation defects

422

0.73

0.98

1.3

1.1

0.88

0.87

g/l

0.09

422

Drug-induced adrenocortical insufficiency

247

0.64

0.97

2.7

1.1

0.88

0.91

g/l

0.32

247

Pyoderma

247

0.64

0.97

1.2

0.84

0.90

g/l

0.40

247

Other crystal arthropathies

108

1.59

0.97

1.5

1.2

0.84

0.89

g/l

0.38

108

Other infestations, including avohilmo

199

1.42

0.97

1.2

0.89

0.91

g/l

0.11

199

Failure of sterile precautions during surgical operation

0.00

0.96

0.0

1.2

—

0.85

—

Cervical root disorders

1.68

0.96

1.1

1.2

0.86

0.95

g/l

0.62

Major anomalies of jaw size

489

0.75

0.96

1.2

0.86

0.89

g/l

0.45

489

Other operation for atrial fibrillation

0.00

0.96

0.0

1.3

—

0.87

—

Cardiomyopathy in other diseases

0.00

0.96

0.0

1.3

—

0.93

—

Benign neoplasm: Ciliary body

1.95

0.96

1.3

1.2

0.77

0.88

g/l

—

Congenital malformations of the respiratory system

197

0.60

0.95

1.0

1.2

0.82

0.90

g/l

0.81

197

Malignant melanoma of skin, including Hilmo

132

1527

0.86

0.94

1.2

0.89

g/l

0.05

132

1521

Immunodeficiency with predominantly antibody defects

408

0.73

0.94

1.5

1.2

0.88

0.91

g/l

0.27

408

Other/unspecified mastoiditis and related conditions

1.77

0.94

1.1

1.2

0.75

0.82

g/l

—

Mucocutaneous lymph node syndrome [Kawasaki]

2.23

0.93

1.3

1.1

0.78

0.80

g/l

—

Haemolytic-uraemic syndrome

2.22

0.93

1.7

1.1

0.91

0.83

g/l

—

Other and unspecified intracranial injuries

419

0.73

0.93

1.2

0.82

0.90

g/l

1.37

419

Vascular syndromes of brain in cerebrovascular disorders

257

0.66

0.93

1.5

1.2

0.76

0.91

g/l

1.75

257

Burns and corrosions confined to eye and internal organs

598

0.78

0.93

1.2

0.91

g/l

0.00

598

Other disorders of veins

681

7132

0.94

0.93

1.2

0.86

0.89

g/l

2.65

675

7109

Other and unspecified injuries of shoulder and upper arm

554

0.77

0.93

1.1

1.2

0.90

0.89

g/l

0.07

554

Childhood asthma (age<16), excluding more controls

482

4053

0.92

0.93

1.1

0.87

g/l

0.21

482

4044

Diseases of middle ear and mastoid

1511

12858

0.96

0.92

1.1

0.88

g/l

0.31

1505

12831

ILD medications: acetylcysteine

2.16

0.92

1.3

0.77

0.91

g/l

—

Other surgical follow-up care

575

0.78

0.91

1.2

1.1

0.86

0.87

g/l

0.19

575

194

0.61

0.91

1.2

1.1

0.85

0.86

g/l

0.07

194

Crystal arthropathies, rheuma endpoint

110

1.56

0.91

1.5

1.2

0.84

0.89

g/l

0.36

110

Chronic gastritis

226

2518

0.90

0.91

1.6

1.2

0.89

g/l

0.10

226

2509

Lactose intolerance, other/unspecified

439

0.74

0.90

1.3

1.1

0.85

0.89

g/l

0.49

439

Other and unspecified primary disorders of muscles

105

0.47

0.90

1.4

1.1

1.00

0.88

g/l

—

105

Benign neoplasm: Rectosigmoid junction

325

0.70

0.90

1.6

1.2

0.99

0.90

g/l

0.59

325

Flatulence and related conditions

126

0.55

0.89

1.0

1.1

0.86

0.90

g/l

—

126

Disorders of globe

218

0.64

0.89

1.1

1.2

0.93

0.90

g/l

0.13

218

Polyp of the female genital tract

496

3022

0.93

0.89

1.1

1.2

0.89

0.88

g/l

0.37

491

3011

Golimumab

836

0.82

0.89

1.1

1.2

0.85

0.90

g/l

1.09

836

Postviral fatigue syndrome

216

0.63

0.89

1.1

0.91

0.89

g/l

0.16

216

Other mosquito-borne viral fevers

2.08

0.89

1.0

1.2

0.88

0.87

g/l

—

Erythema intertrigo

300

0.69

0.89

1.8

1.2

0.97

0.92

g/l

0.33

300

Other/unspecified enthesopathies, not elsewhere classified

113

1313

0.86

0.88

1.2

0.94

0.90

g/l

0.87

113

1313

Malignant neoplasm of bone and articular cartilage, including Hilmo

193

0.62

0.88

1.4

1.2

0.87

0.91

g/l

0.31

193

Childhood asthma (age<16)

483

4051

0.93

0.88

1.1

0.87

g/l

0.19

483

4042

Exposure to other specified factors

2091

17330

1.04

0.88

1.1

1.2

0.88

0.89

g/l

0.47

2081

17280

Other and unspecified erythematous conditions

403

0.74

0.88

1.2

0.85

0.90

g/l

0.52

403

Certain infectious and parasitic diseases, including avohilmo

1871

9024

1.04

0.88

1.2

1.1

0.88

0.89

g/l

0.34

1866

8992

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

204

0.63

0.87

1.2

0.83

0.91

g/l

0.51

204

Granulomatous disorders of skin and subcutaneous tissue

402

0.74

0.87

1.1

0.84

0.88

g/l

0.53

402

Prophylactic surgery

162

1.45

0.87

1.1

0.83

0.89

g/l

0.68

162

Idiopathic hypercalciuria

1.71

0.87

1.0

1.1

0.95

0.91

g/l

0.28

Dermatitis and eczema

2845

16336

1.03

0.86

1.2

0.88

0.89

g/l

0.56

2836

16281

Haematosalpinx/Haematoma of broad ligament

2.02

0.86

1.0

1.2

1.07

0.95

g/l

—

Hyperhidrosis

669

0.80

0.86

1.2

1.1

0.88

g/l

0.07

669

Contracture of joint

179

0.61

0.86

1.0

1.2

0.86

0.93

g/l

0.44

179

Secondary right heart disease

228

0.65

0.86

1.1

1.2

0.95

0.89

g/l

0.41

228

Failed attempted abortion

319

0.71

0.85

1.0

1.1

0.89

0.86

g/l

0.38

319

Eclampsia

1.80

0.85

1.0

0.93

0.83

g/l

—

Moderate visual impairment, binocular

179

0.61

0.85

1.3

1.2

0.82

0.89

g/l

0.53

179

Seronegative juvenile rheumatoid arthritis

365

0.73

0.84

1.4

1.1

0.76

0.87

g/l

2.17

365

Scleritis

214

0.64

0.84

1.0

1.1

1.01

0.91

g/l

0.78

214

Other viral diseases, not elsewhere classified

371

4001

0.92

0.84

1.2

1.1

0.87

0.89

g/l

0.49

371

3994

Panniculitis, unspecified

140

0.56

0.84

1.0

1.2

1.00

0.90

g/l

—

140

Burn and corrosion confined to eye and adnexa

522

0.78

0.84

1.1

1.2

0.93

0.91

g/l

0.18

522

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

138

0.58

0.84

1.9

1.2

0.88

0.91

g/l

—

138

Injuries to the knee and lower leg

2892

16081

0.97

0.83

1.2

0.89

0.88

g/l

1.36

2879

16032

Diarrhoea and gastroenteritis of presumed infectious origin

1672

15476

0.96

0.83

1.3

1.1

0.88

0.89

g/l

0.06

1665

15433

Calcaneal spur

177

0.61

0.83

1.3

1.2

0.99

0.91

g/l

0.29

177

Other osteochondrodysplasias

130

1.49

0.83

1.1

0.98

0.92

g/l

0.45

130

Optic atrophy, wide definition

225

0.66

0.82

1.1

0.89

0.90

g/l

0.10

225

Feeding problems of newborn

1.91

0.82

1.2

1.0

0.66

0.75

g/l

—

Malignant melanoma, including Hilmo

162

1826

0.88

0.82

1.3

1.2

0.90

0.89

g/l

0.12

162

1817

Malignant neoplasm of other connective and soft tissue

213

0.65

0.82

1.1

1.2

0.96

0.91

g/l

0.29

213

Contusion of toe(s) with damage to nail

212

0.65

0.82

1.0

1.1

0.94

0.89

g/l

0.23

212

Brain mixed glioma, helper endpoint

0.00

0.82

0.0

1.0

—

0.97

—

Infective bursitis

431

0.76

0.81

1.4

1.2

0.84

0.90

g/l

0.73

431

Disorders of breast

971

8960

0.95

0.81

1.1

0.87

g/l

0.73

965

8934

Other and unspecified firearm discharge, undetermined intent

0.00

0.81

0.0

1.2

—

0.94

—

Brain mixed glioma

0.00

0.81

0.0

1.1

—

0.95

—

Drug-induced Cushing's syndrome

0.00

0.81

0.0

1.3

—

0.84

—

Disease of thymus, other/unspecified

0.00

0.81

0.0

1.1

—

0.83

—

Drug-induced hypoglycaemia without coma

188

0.63

0.81

1.8

1.1

0.68

0.90

g/l

1.96

188

Intentional self-harm by crashing of motor vehicle

0.00

0.81

0.0

1.3

—

0.89

—

Foreign body in genitourinary tract

147

0.60

0.80

1.2

1.1

0.83

0.88

g/l

—

147

Other congenital malformations of intestine

106

1.54

0.80

1.5

1.1

0.94

0.91

g/l

0.14

106

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

0.80

0.0

1.3

—

0.81

—

Immunodeficiency associated with other major defects

0.00

0.80

0.0

1.1

—

0.93

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.80

0.0

1.3

—

0.83

—

Open wound of hip and thigh

662

0.81

0.80

1.3

1.2

0.90

g/l

0.03

662

Fistulae involving female genital tract

190

1.38

0.80

1.2

0.95

0.93

g/l

0.24

190

Patent foramen ovale

366

1.27

0.80

1.2

0.78

0.91

g/l

2.42

366

Iridocyclitis in diseases classified elsewhere

235

0.67

0.80

1.1

1.2

0.96

0.91

g/l

0.39

235

Cholera, including avohilmo

0.00

0.80

0.0

1.2

—

0.83

—

Intentional self-harm by drowning and submersion

0.00

0.80

0.0

1.2

—

0.93

—

Hypertensive encephalopathy

0.00

0.80

0.0

1.1

—

0.90

—

Unspecified organic or symptomatic mental disorder

0.00

0.80

0.0

1.3

—

0.85

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.80

0.0

1.2

—

0.81

—

Malignant melanoma

142

1609

0.88

0.79

1.2

0.91

0.89

g/l

0.53

142

1601

Drug-induced myopathy

0.00

0.79

0.0

1.3

—

0.89

—

Other melanin hyperpigmentation

173

1.40

0.79

1.3

1.2

0.88

0.92

g/l

0.27

173

Other and unspecified pemphigus

0.00

0.79

0.0

1.2

—

0.93

—

Impacted maxillary canine

1.58

0.79

1.1

1.2

0.84

0.81

g/l

0.18

Other sideroblastic anaemias

0.00

0.79

0.0

1.1

—

0.87

—

Aortic arch syndrome [Takayasu]

0.00

0.79

0.0

1.1

—

0.81

—

Other bursitis of hip

246

0.68

0.79

1.1

1.2

0.81

0.91

g/l

1.32

246

Open bite that required surgery (Lefort1 or BSSO)

235

1.35

0.78

1.1

0.91

0.88

g/l

0.26

235

Adenocarcinoma and Papillary adenocarcinoma of kidney

0.50

0.78

2.0

1.2

1.10

0.92

g/l

—

Other misadventures during surgical and medical care

269

0.70

0.78

1.1

1.2

0.97

0.90

g/l

0.58

269

Restrictive cardiomyopathy

0.00

0.78

0.0

1.3

—

0.91

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.78

0.0

1.4

—

0.88

—

Craniosynostosis EXCLUDE syndromes

2.25

0.78

1.0

1.3

0.76

0.92

g/l

—

Malignant neoplasm of bladder, including Hilmo

533

0.79

0.77

1.6

1.3

0.86

0.88

g/l

0.22

527

Primary angle-closure glaucoma

222

0.67

0.77

1.3

1.2

0.73

0.92

g/l

3.34

222

Lesion of medial popliteal nerve

1.74

0.77

1.0

1.2

0.93

0.94

g/l

—

Myositis

325

0.73

0.77

1.5

1.2

0.91

g/l

0.02

325

LSIL lesion of the vulva

548

0.79

0.76

1.3

1.2

0.92

0.90

g/l

0.30

548

Other specified and unspecified strabismus

173

0.63

0.76

1.2

1.1

0.94

0.90

g/l

0.15

173

Other infections specific to the perinatal period

1.73

0.76

1.7

1.0

0.99

0.79

g/l

—

Pneumonia derived septicemia

404

0.76

1.4

1.2

0.91

0.90

g/l

0.05

404

Bacterial meningitis

569

0.80

0.75

1.1

1.2

0.87

0.90

g/l

0.41

569

Social disorders starting during childhood or adolescence

133

0.59

0.75

1.6

1.0

0.75

0.89

g/l

—

133

Other and unspecified diseases of blood and blood-forming organs

280

1.30

0.75

1.6

1.2

0.87

0.91

g/l

0.31

280

Keratoconus

506

1.22

0.75

1.3

1.2

0.90

0.93

g/l

0.37

506

Dermatitis herpetiformis

184

0.65

0.74

1.1

0.91

0.89

g/l

0.13

184

Nasal polyp

342

3168

1.08

0.74

1.2

0.86

0.90

g/l

2.64

342

3160

Other erythematous conditions

458

0.78

0.74

1.2

0.85

0.90

g/l

0.57

458

Benign neoplasm: Skin of lip

133

0.60

0.74

1.4

1.2

0.78

0.91

g/l

—

133

Defect, injury or illness of face

2.08

0.74

1.4

1.1

0.96

0.90

g/l

—

Chorioretinal inflammation

435

0.77

0.74

1.2

0.90

0.91

g/l

0.09

435

Hereditary ataxia

136

0.58

0.74

2.4

1.2

0.86

0.89

g/l

—

136

Dermatitis due to substances taken internally

840

0.84

0.73

1.4

1.2

0.88

0.89

g/l

0.06

840

Other bursitis of elbow

108

0.55

0.73

1.0

1.1

0.88

0.89

g/l

—

108

Corneal ulcer

370

3976

0.93

0.73

1.1

1.2

0.91

0.89

g/l

0.73

370

3969

Congenital malformations of great veins

2.03

0.73

2.0

1.5

0.73

0.81

g/l

—

Atrial septal defect

574

0.81

0.73

1.2

0.82

0.90

g/l

1.63

574

Bullous pemphigoid

107

0.56

0.73

1.8

1.2

0.66

0.89

g/l

—

107

Other and specified injuries of hip and thigh

230

0.69

0.73

1.0

1.2

0.83

0.88

g/l

0.37

230

Abnormal findings in nipple discharge synovial fluid wound secretions

206

0.67

0.72

1.1

0.81

0.89

g/l

0.77

206

Osteoporosis

187

1903

0.90

0.72

2.0

1.2

0.87

0.90

g/l

0.60

187

1896

Pneumococcal septicemia

378

0.76

0.72

1.4

1.2

0.92

0.90

g/l

0.21

378

Hypertrichosis

510

0.79

0.72

1.1

0.86

g/l

0.07

510

Nephrotic syndrome

400

0.77

0.72

1.5

1.2

0.90

0.91

g/l

0.08

400

Injury of nerves at shoulder and upper arm level

158

0.62

0.72

1.0

1.2

0.89

0.91

g/l

—

158

Other osteochondrodysplasias, including avohilmo

160

1.39

0.71

1.1

1.2

0.95

0.92

g/l

0.17

160

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

126

1.45

0.71

1.0

1.1

0.86

0.80

g/l

0.60

126

Other and unspecified acne

308

0.74

0.71

1.1

0.97

0.87

g/l

0.94

308

Malignant neoplasm of cervix uteri

297

0.73

0.71

1.1

1.2

0.95

0.87

g/l

0.91

297

118

1.47

0.71

1.2

1.1

0.84

0.93

g/l

0.63

118

Graves ophthalmopathy

365

0.76

0.71

1.0

1.2

0.95

0.90

g/l

0.42

365

Exposure to unspecified smoke, fire and flames

145

0.61

0.71

1.2

1.1

0.87

0.91

g/l

—

145

Melanocytic naevi of scalp and neck

376

0.76

0.70

1.6

1.2

0.82

0.89

g/l

1.51

376

Endometriosis in cutaneous scar

1.69

0.70

1.1

1.2

0.91

0.89

g/l

—

Injuries to the ankle and foot

1944

17102

0.97

0.70

1.1

0.89

0.88

g/l

0.43

1937

17057

Disorders of eyelid in diseases classified elsewhere

476

0.79

0.70

1.1

0.90

g/l

0.01

476

Testicular dysfunction, other/unspecified

119

0.57

0.70

1.1

0.97

0.93

g/l

—

119

Other abnormal auditory perceptions

192

0.67

0.69

1.2

1.1

0.92

0.88

g/l

0.28

192

Dislocation, sprain and strain of joint and ligaments of hip

353

0.76

0.69

1.2

0.86

0.91

g/l

0.62

353

Palatinal maxillary operation

119

0.58

0.69

1.0

0.80

0.81

g/l

—

119

Disorders of lacrimal system and orbit in diseases classified elsewhere

374

0.77

0.68

1.1

1.2

0.96

0.90

g/l

0.52

374

Congenital malformations of spine and bony thorax

0.53

0.68

1.0

1.2

0.76

0.93

g/l

—

Need for immunization against other single viral diseases

295

0.74

0.68

1.5

1.1

0.91

0.90

g/l

0.02

295

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

614

0.82

0.68

1.1

0.90

0.89

g/l

0.11

614

Benign neoplasm: Other and unspecified parts of small intestine

119

0.58

0.68

1.3

1.2

0.78

0.91

g/l

—

119

Dislocations, sprains and strains involving multiple body regions

1.87

0.68

1.4

1.1

0.79

0.81

g/l

—

Congenital ptosis

1.66

0.68

1.0

1.2

0.91

0.83

g/l

—

Other hereditary haemolytic anaemias

0.52

0.68

1.0

1.2

0.85

0.88

g/l

—

Other primary thrombocytopenia

1.66

0.68

1.4

1.3

0.90

0.88

g/l

—

Effects of heat and light

0.52

0.68

1.2

1.1

0.79

0.90

g/l

—

Encephalopathy

1.51

0.67

2.1

1.1

0.87

0.93

g/l

0.26

Pedal cyclist injured in collision with motor vehicle

558

1.19

0.67

1.1

0.90

g/l

0.06

558

Melanocytic naevi of upper limb, including shoulder

362

0.77

0.67

1.2

1.1

0.84

0.90

g/l

0.63

362

Other and unspecified hypertrophic disorders of skin

111

1.47

0.67

1.4

1.1

0.82

0.87

g/l

0.63

111

Malignant neoplasm of vulva, including Hilmo

0.54

0.67

1.2

0.88

0.91

g/l

—

Cleft palate

215

1.32

0.67

1.1

0.98

0.89

g/l

1.06

215

Biliary cirrhosis, NAS

1.82

0.67

3.0

1.4

0.68

0.86

g/l

—

Other localized connective tissue disorders

237

0.71

0.67

1.4

1.1

0.93

0.89

g/l

0.29

237

Other assisted single delivery

449

0.79

0.67

1.1

0.81

0.87

g/l

0.95

449

Shoulder region

202

0.69

0.67

1.1

0.72

0.93

g/l

3.31

202

Other disorders of choroid

111

1.45

0.66

1.3

1.2

0.94

0.88

g/l

0.40

111

Abnormal findings in cerebrospinal fluid

1.63

0.66

2.0

1.1

0.88

0.89

g/l

—

Vascular diseases of the intestine

214

0.70

0.66

2.9

1.3

0.97

0.91

g/l

0.42

214

Tularaemia, including avohilmo

286

1.27

0.66

1.1

0.86

0.91

g/l

0.76

286

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.64

0.66

1.1

0.96

0.87

g/l

—

Use of rasagiline

155

0.64

0.66

1.2

0.82

0.91

g/l

—

155

Papilloedema, unspecified

340

1.25

0.66

1.1

1.2

0.90

0.88

g/l

0.21

340

Chronic hepatitis NAS

154

1.38

0.66

3.0

1.2

0.88

0.92

g/l

0.39

154

Other and unspecified corneal deformities and disorders

548

0.81

0.66

1.0

1.2

0.94

0.90

g/l

0.58

548

Periodontal disease, other/unspecified

405

0.78

0.66

1.1

1.2

0.89

g/l

0.07

405

Optic atrophy

213

0.70

0.65

1.1

0.89

0.90

g/l

0.12

213

Corneal scars and opacities

349

0.77

0.65

1.4

1.2

0.93

0.91

g/l

0.14

349

Benign neoplasm: Pharynx, unspecified

1.50

0.65

1.1

0.81

0.89

g/l

0.76

Generalized epilepsy, strict definition

415

0.79

0.65

1.1

0.91

0.89

g/l

0.20

415

Other obstructive and reflux uropathy

656

0.83

0.65

1.1

0.91

0.87

g/l

0.27

656

Other acquired deformities of ankle and foot

131

0.60

0.65

1.1

1.2

1.02

0.92

g/l

—

131

Other congenital malformations of face and neck

568

0.82

0.64

1.1

0.89

g/l

0.03

568

Spasmodic torticollis

470

0.80

0.64

1.2

0.85

0.90

g/l

0.82

470

Operations for atrial fibrillation

129

0.61

0.64

1.4

1.3

1.15

0.89

g/l

—

129

Exclusion endpoint for clefts

347

0.77

0.64

1.0

1.1

0.89

g/l

0.00

347

Other intracranial haemorrhages

154

0.65

0.64

1.1

1.2

0.86

0.89

g/l

—

154

Fungal Sepsis

448

0.80

0.64

1.6

1.2

0.89

0.90

g/l

0.07

448

Tuberculosis of other organs, strict, including avohilmo

129

0.62

0.64

1.0

1.3

0.84

0.91

g/l

—

129

Lactose intolerance

524

0.81

0.64

1.2

0.85

0.88

g/l

0.37

524

Vertical strabismus

502

0.81

0.63

1.1

1.2

0.81

0.91

g/l

2.56

502

Airway disease due to specific organic dust

1.65

0.63

1.1

0.73

0.90

g/l

—

Pregnancy examination and test

452

2972

0.94

0.63

1.1

0.84

0.86

g/l

1.57

452

2965

Somnolence

176

0.67

0.63

1.3

1.1

0.74

0.89

g/l

1.95

176

Lesion of femoral nerve

105

0.56

0.63

1.2

0.88

0.92

g/l

—

105

Pediculosis, acariasis and other infestations, including avohilmo

449

4234

1.06

0.63

1.1

0.89

0.88

g/l

0.53

449

4226

Toxic effect of carbon monoxide

245

0.73

0.62

1.1

0.94

0.91

g/l

0.29

245

Chronic myeloid leukaemia, including Hilmo

105

0.56

0.62

1.2

1.1

0.80

0.90

g/l

—

105

Postdysenteric arthropathy

152

0.65

0.62

1.2

1.1

0.89

0.90

g/l

—

152

Dextrocardia

0.00

0.62

0.0

1.3

—

0.81

—

hereditary angioödema type 3

0.00

0.62

0.0

1.1

—

0.81

—

Localized hypertrichosis

0.00

0.62

0.0

1.1

—

0.82

—

Linear scleroderma

0.00

0.62

0.0

1.1

—

0.85

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

102

0.58

0.62

1.0

1.2

0.92

0.89

g/l

—

102

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.62

0.0

1.1

—

1.00

—

Edwards' syndrome and Patau's syndrome

0.00

0.62

0.0

1.1

—

0.80

—

Contact urticaria

1.61

0.62

1.0

1.1

0.97

0.84

g/l

—

General autosomal fish scale disease

0.00

0.61

0.0

1.1

—

0.86

—

Acné excoriée

0.00

0.61

0.0

1.0

—

0.84

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.61

0.0

1.4

—

0.91

—

Obstetric embolism

0.00

0.61

0.0

1.1

—

0.86

—

Other and unspecified injuries of forearm

141

0.63

0.61

1.0

1.1

0.78

0.90

g/l

—

141

Congenital heart conduction disorder

0.00

0.61

0.0

1.2

—

0.80

—

Haemophagocytic lymphohistiocytosis

0.00

0.61

0.0

1.2

—

0.79

—

Cryoglobulinemia

0.00

0.61

0.0

1.3

—

0.84

—

Unspecified severe protein-energy malnutrition

0.00

0.61

0.0

1.5

—

0.79

—

Congenital malformations of anterior segment of eye

105

1.45

0.61

1.0

1.2

0.89

0.90

g/l

0.03

105

Venous complications and haemorrhoids in the puerperium

163

0.67

0.61

1.2

1.04

0.89

g/l

0.75

163

Explosion and rupture of other specified pressurized devices

0.00

0.61

0.0

1.1

—

1.05

—

Tularaemia

174

1.34

0.61

1.1

0.87

0.91

g/l

0.28

174

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

0.61

0.0

1.4

—

0.92

—

Inflammation of lacrimal passages (acute and unspecified)

218

1.30

0.61

1.1

0.91

0.90

g/l

0.09

218

Cardiovascular disorders originating in the perinatal period

0.00

0.61

0.0

1.3

—

0.85

—

Reduction defects of unspecified limb, including avohilmo

0.00

0.61

0.0

1.4

—

0.88

—

Induced delusional disorder

0.00

0.61

0.0

1.1

—

0.91

—

Acquired haemolytic anaemia

218

1.29

0.60

1.8

1.2

0.90

g/l

0.00

218

Intentional self-harm by other and unspecified firearm discharge

0.00

0.60

0.0

1.3

—

0.84

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

192

1.32

0.60

1.1

1.2

0.93

0.91

g/l

0.14

192

Erythema in diseases classified elsewhere

0.00

0.60

0.0

1.2

—

0.86

—

Degenerative macular diseases, drug-induced

0.00

0.60

0.0

1.4

—

0.85

—

Autonomic disorders

366

0.79

0.60

1.0

1.2

0.93

0.91

g/l

0.09

366

Injury of nerves at forearm level

231

0.73

0.59

1.0

1.1

0.93

0.91

g/l

0.09

231

Overjet

325

1.23

0.59

1.2

1.1

0.87

0.86

g/l

0.19

325

Cyclic neutropenia

0.00

0.59

0.0

1.0

—

0.82

—

Other disorders of eyelid

503

4495

1.06

0.59

1.2

0.89

g/l

0.09

498

4468

Primary adrenocortical insufficiency

150

0.66

0.59

1.9

1.2

0.90

g/l

—

150

Other, unspecified and serous retinal detachments

336

1.23

0.59

1.2

0.83

0.92

g/l

1.48

336

Other superficial injuries of ankle and foot

106

1.44

0.59

1.0

1.2

0.84

0.90

g/l

0.56

106

Ectopic pregnancy

322

3440

0.93

0.59

1.1

1.2

0.88

g/l

0.22

322

3432

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

113

0.61

0.59

1.7

1.1

0.90

g/l

—

113

Choroidal haemorrhage and rupture

0.00

0.59

0.0

1.3

—

0.83

—

Injury of nerves at lower leg level

173

0.68

0.59

1.2

1.1

1.03

0.90

g/l

0.50

173

Malignant neoplasm of cervix uteri, including Hilmo

365

0.79

0.59

1.1

1.2

0.96

0.87

g/l

1.21

365

Other pulmonary heart/vessel disease

254

0.75

0.59

1.3

1.2

0.94

0.89

g/l

0.38

254

Infection due to other mycobacteria, including avohilmo

150

0.66

0.58

1.0

1.2

1.01

0.91

g/l

—

150

therapeutic use

242

0.74

0.58

1.6

1.3

0.89

0.92

g/l

0.13

242

Asymmetry of jaw

283

1.25

0.58

1.1

0.86

0.89

g/l

0.49

283

Collapsed vertebra, not elsewhere classified

1.73

0.58

1.3

1.36

0.89

g/l

—

Other and unspecified disease of Bartholin gland

320

0.78

0.58

1.0

1.2

0.86

0.89

g/l

0.21

320

Benign neoplasm: Larynx

309

0.77

0.58

1.4

1.2

0.85

0.90

g/l

0.47

309

Atopic conjunctivitis

871

0.87

0.57

1.1

0.85

0.88

g/l

0.56

871

Benign neoplasm: Hypopharynx

1.69

0.57

1.0

1.2

1.00

0.91

g/l

—

Marfan's syndrome

107

1.43

0.57

1.0

1.1

0.93

0.91

g/l

0.11

107

Unspecified transport accident

0.54

0.57

1.0

1.2

0.90

0.92

g/l

—

Cellulitis of external ear

172

0.69

0.57

1.0

1.1

0.85

0.89

g/l

0.20

172

Congenital ptosis, including avohilmo

1.48

0.57

1.0

1.1

0.91

0.81

g/l

—

Intercostal neuropathy

0.55

0.57

1.2

1.14

0.90

g/l

—

Benign neoplasm: Skin, unspecified

581

0.84

0.56

1.1

1.2

0.89

0.90

g/l

0.09

581

Problems related to social environment

363

0.79

0.56

1.4

1.2

0.92

0.89

g/l

0.34

363

Chronic myeloproliferative disease

0.56

1.4

1.2

0.85

0.89

g/l

—

Other protozoal intestinal diseases, including avohilmo

412

1.20

0.56

1.2

1.1

0.86

0.88

g/l

0.38

412

Use of dimethyl fumarate

205

0.72

0.56

1.2

1.1

0.83

0.89

g/l

0.55

205

Benign neoplasm of other and unspecified female genital organs

494

0.83

0.56

1.1

1.2

0.88

g/l

0.00

494

Cystic kidney disease, including avohilmo

472

0.82

0.56

2.1

1.2

0.86

0.90

g/l

0.73

472

Yaws, including avohilmo

1.56

0.56

1.0

1.2

1.01

0.88

g/l

—

Other congenital malformations of male genital organs, including avohilmo

124

0.64

0.56

1.0

1.1

0.88

0.92

g/l

—

124

Exposure to other and unspecified animate mechanical forces

673

1.15

0.56

1.1

0.92

0.89

g/l

0.69

673

Cystic kidney disease

428

0.81

0.56

2.2

1.2

0.85

0.90

g/l

0.69

428

Atypical virus infections of central nervous system

124

0.64

0.55

1.0

1.2

0.82

0.88

g/l

—

124

Polyarteritis nodosa and related conditions

171

0.69

0.55

1.3

1.1

0.84

0.89

g/l

0.48

171

Meckel's diverticulum

1.49

0.55

1.1

0.95

0.88

g/l

0.38

Atypical virus infections of central nervous system, including avohilmo

125

0.63

0.55

1.0

1.2

0.82

0.88

g/l

—

125

Mumps, including avohilmo

557

0.84

0.55

1.0

1.2

0.87

0.91

g/l

0.58

557

Other specified disorders of muscle

525

0.83

0.55

1.2

0.92

0.91

g/l

0.06

525

Epidural haemorrhage

159

0.68

0.55

1.0

1.2

0.91

0.92

g/l

0.02

159

Tetralogy of Fallot, a congenital heart defect.

1.51

0.55

1.0

1.2

0.86

0.93

g/l

—

Other abnormal immunological findings in serum

317

0.78

0.55

1.0

1.2

0.92

0.89

g/l

0.18

317

Acquired pure red cell aplasia [erythroblastopenia]

1.60

0.55

1.5

1.2

0.77

0.88

g/l

—

Supernumerary teeth EXCLUDE clefts and syndromes

1.52

0.55

1.0

1.1

0.88

0.87

g/l

0.06

Congenital cataract

1.50

0.55

1.1

0.91

0.85

g/l

—

Sequelae of other accidents

182

0.71

0.54

1.0

1.2

0.90

g/l

0.00

182

Tuberculosis of other organs, strict

125

0.64

0.54

1.0

1.2

0.84

0.91

g/l

—

125

Drug-induced acute pancreatitis

1.59

0.54

1.0

1.1

0.94

0.93

g/l

—

Benign neoplasm: Scapula and long bones of upper limb

170

0.70

0.54

1.0

1.1

0.84

0.91

g/l

0.52

170

Certain zoonotic bacterial diseases, including avohilmo

395

1.20

0.54

1.1

1.2

0.88

0.91

g/l

0.41

395

Acute appendicitis, no complications

1541

14888

1.03

0.54

1.1

1.2

0.90

0.89

g/l

0.64

1536

14854

Viral conjunctivitis, including avohilmo

791

0.87

0.54

1.1

0.87

0.88

g/l

0.15

791

Cleft lip and cleft lip and palate

146

0.67

0.53

1.3

1.1

0.88

0.92

g/l

—

146

Drug-induced headache, not elsewhere classified

0.61

0.53

1.7

1.1

0.89

0.87

g/l

—

Cleft hard palate NOS

1.48

0.53

1.2

1.1

0.93

0.86

g/l

0.41

Hypoparathyroidism

338

0.79

0.53

2.0

1.2

0.90

0.91

g/l

0.10

338

Acute lymphocytic leukaemia, helper endpoint

0.62

0.53

1.2

1.1

0.84

0.86

g/l

—

Acute lymphocytic leukaemia

0.62

0.53

1.2

1.1

0.84

0.86

g/l

—

Acute lymphocytic leukaemia, including Hilmo

0.62

0.53

1.2

1.1

0.84

0.86

g/l

—

Other diseases of lip and oral mucosa

757

7876

0.96

0.53

1.2

0.88

0.89

g/l

0.85

752

7854

Congenital obstruction of the pelviureteric junction

126

1.37

0.53

1.4

1.1

0.86

0.92

g/l

0.55

126

Other disorders affecting eyelid function

0.61

0.53

1.0

1.2

0.81

0.87

g/l

—

Glaucoma secondary to eye inflammation

0.61

0.53

1.3

1.1

0.83

0.92

g/l

—

Burns and corrosions of multiple body regions

135

0.66

0.52

1.0

1.1

0.95

0.90

g/l

—

135

Turner's syndrome

1.53

0.52

1.2

1.1

0.96

0.86

g/l

—

Other secondary coxarthrosis

403

0.81

0.52

1.2

0.97

0.90

g/l

1.02

403

Orthopaedic devices associated with adverse incidents

0.62

0.52

1.2

1.3

0.76

0.89

g/l

—

Alcohol induced polyneuropathy

100

0.59

0.52

2.7

1.3

0.94

0.88

g/l

—

100

Acute poliomyelitis

135

0.66

0.52

1.2

1.1

0.82

0.89

g/l

—

135

Acute poliomyelitis, including avohilmo

135

0.66

0.52

1.2

1.1

0.82

0.89

g/l

—

135

Acute epiglottitis

281

0.77

0.52

1.0

1.2

0.95

0.91

g/l

0.23

281

Malignant neoplasm of other and unspecified parts of biliary tract

100

0.60

0.52

2.2

1.2

0.94

0.91

g/l

—

100

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

225

0.75

0.52

1.0

1.2

0.85

0.90

g/l

0.35

225

Mumps

542

0.84

0.52

1.0

1.2

0.87

0.90

g/l

0.44

542

Exposure to other and unspecified man-made environmental factors

361

1.20

0.51

1.1

1.2

0.92

0.90

g/l

0.19

361

Unspecified threat to breathing

144

1.34

0.51

1.0

1.1

0.86

g/l

0.01

144

Erosion and ectropion of cervix uteri

269

1.23

0.51

1.1

1.2

0.88

0.91

g/l

0.28

269

Unspecified maternal hypertension

313

0.79

0.51

1.1

0.89

0.84

g/l

0.64

313

Migraine with aura, drug-induced

179

0.72

0.51

1.2

0.87

0.92

g/l

0.27

179

Xerosis cutis

145

0.69

0.51

1.5

1.2

0.93

0.91

g/l

—

145

Carcinoma in situ of cervix uteri, exocervix

144

0.68

0.50

1.0

1.2

0.93

0.90

g/l

—

144

Atypical facial pain

840

0.88

0.50

1.1

1.2

0.90

0.89

g/l

0.10

840

Other articular cartilage disorders

346

0.80

0.50

1.3

1.2

0.95

0.91

g/l

0.44

346

Multiple congenital exostoses

1.60

0.50

1.1

1.08

0.90

g/l

—

Benign neoplasm: Connective and other soft tissue of pelvis

1.60

0.50

1.0

1.2

0.89

0.81

g/l

—

Hereditary corneal dystrophies

302

0.79

0.50

1.8

1.2

0.92

g/l

0.02

302

Mandibular hypoplasia

110

1.39

0.50

1.2

1.1

0.86

0.87

g/l

0.03

110

Cleft lip and palate

109

0.63

0.50

1.4

1.1

0.88

0.89

g/l

—

109

Other and unspecified vaccines and biological substances

109

0.63

0.49

2.0

1.1

0.83

g/l

—

109

Autoimmune hepatitis

110

1.38

0.49

2.6

1.2

0.84

0.92

g/l

0.79

110

Traction detachment of retina

106

0.65

0.49

1.9

1.1

0.87

0.92

g/l

—

106

Hereditary motor and sensory neuropathy

108

0.64

0.49

1.0

1.1

1.00

0.90

g/l

—

108

Pedestrian injured in collision with car, pick-up truck or van

334

0.80

0.49

1.1

0.91

0.90

g/l

0.07

334

Exposure to uncontrolled fire in building or structure

110

0.63

0.49

1.0

1.1

0.87

0.92

g/l

—

110

Combined immunodeficiencies

106

0.65

0.49

1.1

1.2

0.88

0.89

g/l

—

106

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

181

1.29

0.49

1.1

0.88

0.87

g/l

0.06

181

Benign neoplasm: Small intestine

301

0.79

0.49

1.8

1.2

0.82

0.91

g/l

1.24

301

Conotruncal defects

181

1.28

0.49

1.0

1.1

0.85

0.89

g/l

0.30

181

Gastrojejunal ulcer

110

0.63

0.49

1.3

1.1

0.83

0.91

g/l

—

110

Injury of urinary and pelvic organs

311

0.80

0.48

1.6

1.1

0.92

0.91

g/l

0.01

311

Follicular adenocarcinoma of thyroid gland, including Hilmo

128

1.34

0.48

1.1

1.2

0.89

0.87

g/l

0.20

128

Benign neoplasm: Tonsil

143

0.69

0.48

1.3

1.2

1.00

0.89

g/l

—

143

Ankylosis of teeth

1.51

0.48

1.4

1.2

0.80

0.91

g/l

—

conjunctival degenerations and deposits

200

0.75

0.48

1.3

1.2

0.91

0.92

g/l

0.08

200

Excessive earwax

1107

9721

1.03

0.48

1.2

0.87

0.89

g/l

3.75

1102

9681

Residual foreign body in soft tissue

1078

0.90

0.48

1.2

0.90

g/l

0.01

1078

Colorectal neuroendocrine tumor and carcinoma

177

0.73

0.48

1.1

1.2

0.89

0.91

g/l

0.13

177

Complications following infusion, transfusion and therapeutic injection

177

0.73

0.48

1.2

0.92

0.90

g/l

0.08

177

Other and unspecified injuries of abdomen, lower back and pelvis

233

0.77

0.48

1.4

1.1

0.98

0.90

g/l

0.52

233

Hirsutism in women

451

0.83

0.47

1.1

0.87

0.85

g/l

0.22

451

Other disorders of optic [2nd] nerve and visual pathways

899

0.89

0.47

1.2

0.89

0.88

g/l

0.11

899

CR(E)ST syndrome

188

0.74

0.47

1.1

1.2

0.90

0.92

g/l

0.12

188

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

307

2894

1.06

0.47

1.2

0.91

0.89

g/l

0.93

307

2888

Other and unspecified injuries of thorax

277

0.79

0.47

1.5

1.1

0.97

0.91

g/l

0.46

277

Congenital malformations of cardiac chambers and connections

1.41

0.47

1.2

1.1

0.84

0.90

g/l

0.41

Toxoplasmosis

0.61

0.47

1.2

1.1

0.70

0.89

g/l

—

Other benign neoplasm of uterus: Cervix uteri

0.61

0.46

1.0

1.1

0.81

0.88

g/l

—

Graves ophthalmopathy, strict

331

0.81

0.46

1.0

1.2

0.96

0.90

g/l

0.48

331

Contracture of muscle

1.45

0.46

1.1

0.78

0.89

g/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.60

0.46

1.0

1.1

0.86

0.92

g/l

—

Calcific tendinitis

138

1.32

0.46

1.3

1.2

0.81

0.91

g/l

1.01

138

Open wound of wrist and hand

1153

11462

0.97

0.46

1.1

1.2

0.91

0.89

g/l

1.92

1148

11434

Lumbosacral root disorders, not elsewhere classified

120

0.66

0.46

1.0

1.1

0.84

0.94

g/l

—

120

Implicit fungal Sepsis

407

0.83

0.46

1.6

1.2

0.90

g/l

0.02

407

Respiratory tuberculosis, confirmed, including avohilmo

117

0.68

0.46

1.1

1.2

0.79

0.89

g/l

—

117

Birth injury to peripheral nervous system

1.42

0.46

1.3

1.0

0.88

0.83

g/l

—

Campylobacter enteritis

431

1.17

0.46

1.4

1.2

0.86

0.91

g/l

0.97

431

Asthma, including avohilmo

3014

16284

1.02

0.46

1.2

0.88

0.89

g/l

1.10

3004

16231

Scabies, including avohilmo

397

3778

1.05

0.45

1.1

0.89

0.88

g/l

0.41

397

3770

Injury of blood vessels at abdomen, lower back and pelvis level

1.42

0.45

1.4

1.2

0.88

g/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

120

0.66

0.45

1.1

1.3

0.82

0.92

g/l

—

120

Benign neoplasm: Sigmoid colon

171

1846

0.92

0.45

1.4

1.3

0.85

0.90

g/l

1.80

171

1841

Maternal care for cervical incompetence

567

0.86

0.45

1.1

0.82

0.84

g/l

0.37

567

Ovarian cyst

678

4028

0.96

0.45

1.2

1.1

0.87

0.86

g/l

0.52

678

4016

Complications of anaesthesia during labour and delivery

1.44

0.44

1.5

1.0

0.86

0.82

g/l

0.25

Burns classified according to extent of body surface involved

139

1.31

0.44

1.3

1.2

0.89

0.91

g/l

0.09

139

Cyst of iris, ciliary body and anterior chamber

1.66

0.44

1.6

1.1

0.84

0.94

g/l

—

Other congenital malformations, not elsewhere classified

129

0.69

0.44

1.1

0.85

0.90

g/l

—

129

Unspecified nephritic syndrome

274

0.80

0.44

1.2

0.86

0.89

g/l

0.39

274

Other immunodeficiencies

140

0.71

0.44

1.6

1.1

0.87

0.88

g/l

—

140

Personal history of medical treatment

128

0.70

0.44

2.0

1.1

0.91

0.90

g/l

—

128

Acute pharyngitis

418

4334

0.95

0.44

1.2

1.1

0.87

0.88

g/l

0.28

418

4327

Meningococcal infection, including avohilmo

151

0.72

0.44

1.0

1.1

0.95

0.92

g/l

0.23

151

Other and unspecified mononeuropathies of upper limb

522

0.86

0.44

1.1

1.2

0.88

0.91

g/l

0.26

522

Dissection of aorta

230

0.78

0.43

1.2

1.3

0.97

0.91

g/l

0.43

230

Multiple congenital exostoses, including avohilmo

1.44

0.43

1.1

1.05

0.91

g/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

113

1.34

0.43

1.0

1.1

0.88

0.80

g/l

0.78

113

Abscess of external ear

218

0.77

0.43

1.3

1.1

0.90

0.91

g/l

0.05

218

Whooping cough, including avohilmo

378

1.17

0.43

1.2

1.1

0.84

0.87

g/l

0.51

378

Defect, injury or illness of neck

0.65

0.43

1.0

1.1

0.81

0.88

g/l

—

Common variable immunodeficiency

0.64

0.43

1.0

1.1

1.03

0.91

g/l

—

LSIL lesion of the vagina

267

1.21

0.43

1.6

1.2

0.91

0.88

g/l

0.33

267

Defects in the complement system

0.63

0.43

1.8

1.2

0.80

0.87

g/l

—

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms

0.00

0.43

0.0

1.3

—

0.80

—

Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms, including avohilmo

0.00

0.43

0.0

1.3

—

0.80

—

Hereditary deficiency of other clotting factors

139

0.71

0.42

1.3

1.2

0.88

g/l

—

139

Follicular lymphoma, hilmo

295

0.81

0.42

1.3

1.2

0.90

0.91

g/l

0.08

295

Other disorders originating in the perinatal period

0.63

0.42

1.2

1.1

0.66

0.80

g/l

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

1.42

0.42

1.0

1.1

0.81

0.77

g/l

—

Deep bite that required surgery

283

0.80

0.42

1.3

1.2

0.83

0.91

g/l

1.28

283

Other nonscarring hair loss

184

0.75

0.42

1.0

1.2

0.89

0.87

g/l

0.07

184

Progressive external ophthalmoplegia

0.00

0.42

0.0

1.1

—

0.85

—

Mantle cell lymphoma, including Hilmo

0.64

0.42

1.8

1.3

0.94

0.91

g/l

—

Oesophageal obstruction

251

0.79

0.42

1.4

1.2

0.93

0.90

g/l

0.21

251

Von Hippel-Lindau syndrome

0.00

0.42

0.0

1.2

—

0.87

—

Disorder of thyroid, unspecified

140

1.30

0.42

1.5

1.2

0.80

0.92

g/l

1.50

140

Hirsutism, drug-induced

1.56

0.42

1.8

1.1

0.78

0.85

g/l

—

Diphyllobothriasis and sparganosis, including avohilmo

0.00

0.42

0.0

1.1

—

0.83

—

Malignant neoplasm of small intestine

173

0.75

0.42

1.5

1.2

0.94

0.90

g/l

0.15

173

Other disorders of central nervous system

206

0.77

0.42

1.4

1.1

0.97

0.91

g/l

0.26

206

Adenocarcinomas of cervix

1.40

0.42

1.3

1.1

0.84

0.83

g/l

—

Hereditary lymphedema, including avohilmo

1.55

0.42

1.8

1.1

0.72

0.82

g/l

—

Pyogenic granuloma

249

1.21

0.42

1.2

1.1

0.88

0.87

g/l

0.02

249

Pneumoconiosis due to asbestos and other mineral fibres

1.57

0.42

1.4

0.99

0.90

g/l

—

Disorders of fatty-acid metabolism

0.00

0.42

0.0

1.1

—

0.89

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

0.42

0.0

1.3

—

0.91

—

Schistosomiasis [bilharziasis]

0.00

0.42

0.0

1.5

—

0.86

—

Colorectal squamous cell carcinoma

0.00

0.42

0.0

1.1

—

0.88

—

Cholera

0.00

0.42

0.0

1.1

—

0.82

—

Disorders of glycoprotein metabolism

0.00

0.42

0.0

1.3

—

0.91

—

Underdevelopment of the second kidney

0.00

0.42

0.0

1.1

—

0.90

—

Alpha thalassaemia

0.00

0.42

0.0

1.1

—

0.81

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

0.42

0.0

1.0

—

0.93

—

Other degenerative disorders of eyelid and periocular area

1.54

0.42

1.0

1.2

0.95

0.90

g/l

—

Kyphoscoliotic heart disease

0.00

0.42

0.0

1.4

—

0.79

—

Congenital malformation of optic disc

0.00

0.42

0.0

1.6

—

0.90

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.42

0.0

1.3

—

0.83

—

Migraine without aura, drug-induced

213

1.23

0.42

1.0

1.2

0.86

0.91

g/l

0.62

213

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.42

0.0

1.3

—

0.82

—

Disorder of visual pathways, unspecified

0.00

0.42

0.0

1.5

—

0.95

—

Disorder of bilirubin metabolism, other/unspecified

0.00

0.42

0.0

1.5

—

0.89

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

0.42

0.0

1.1

—

0.91

—

Viral agents as the cause of diseases classified to other chapters

337

0.83

0.41

1.4

1.2

0.89

g/l

0.03

337

Endometriosis ASRM stages 1,2

368

3860

0.95

0.41

1.1

0.90

0.87

g/l

1.35

368

3853

Vitamin D deficiency

326

0.82

0.41

1.5

1.1

0.85

0.90

g/l

0.66

326

Compression of brain

0.00

0.41

0.0

1.2

—

0.94

—

Sequelae of intentional self-harm, assault and events of undetermined intent

138

0.71

0.41

1.4

1.1

0.83

0.88

g/l

—

138

Other infective spondylopathies

0.00

0.41

0.0

1.3

—

0.90

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

0.41

0.0

1.1

—

0.96

—

Unspecified renal colic

1.41

0.41

1.1

1.2

0.82

0.90

g/l

0.40

Esophageal diverticulum (pouch), including avohilmo

0.00

0.41

0.0

1.5

—

0.82

—

Enteropathic arthropathies

476

0.86

0.41

1.4

1.1

0.87

0.90

g/l

0.58

476

Abscess of mediastinum

0.00

0.41

0.0

1.1

—

0.98

—

Transient retinal artery occlusion

0.00

0.41

0.0

1.5

—

0.93

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.41

0.0

1.5

—

0.90

—

Thalassaemia trait

0.00

0.41

0.0

1.1

—

0.88

—

Other congenital malformations of intestine, including avohilmo

132

1.30

0.41

1.5

1.1

0.92

g/l

0.00

132

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1745

16229

0.98

0.41

1.2

1.1

0.87

0.89

g/l

2.27

1740

16191

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

168

1.26

0.41

1.0

1.2

0.93

0.91

g/l

0.09

168

Pemphigoid

138

0.72

0.40

1.5

1.2

0.70

0.89

g/l

—

138

Complications of other internal prosthetic devices, implants and grafts

433

0.85

0.40

1.1

1.2

0.84

0.89

g/l

0.83

433

Bilateral cryptorchidism (undescended testicles)

0.00

0.40

0.0

1.2

—

0.90

—

Other lesions of median nerve

238

0.79

0.40

1.2

0.89

0.92

g/l

0.27

238

Other abortion

182

0.76

0.40

1.1

1.00

0.86

g/l

1.25

182

Certain zoonotic bacterial diseases

223

1.22

0.40

1.1

0.91

0.90

g/l

0.06

223

Azathioprine

309

3251

0.95

0.40

1.6

1.1

0.87

0.89

g/l

1.15

309

3245

Frontotemporal dementia

0.00

0.40

0.0

1.4

—

0.95

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

0.40

0.0

1.6

—

0.86

—

Dental pulpitis, including avohilmo

2542

16560

0.98

0.40

1.1

1.2

0.89

0.88

g/l

1.23

2532

16517

Acute generalized exanthematous pustulosis

613

0.88

0.40

1.5

1.2

0.90

0.89

g/l

0.06

613

Pulmonary eosinophilia, not elsewhere classified

102

0.68

0.40

1.3

1.1

0.83

0.91

g/l

—

102

Carcinoid syndrome

1.32

0.40

1.4

1.2

0.99

0.92

g/l

—

Benign neoplasm: Eye, unspecified

1.44

0.39

1.0

1.2

1.07

0.84

g/l

—

Benign neoplasm of other and unspecified intrathoracic organs

106

1.33

0.39

1.9

1.1

0.89

g/l

0.00

106

Other forms of systemic lupus erythematosus

124

1.31

0.39

1.0

1.1

0.83

0.88

g/l

0.33

124

Inhalation of gastric contents

0.00

0.39

0.0

1.1

—

0.90

—

Maternal care for known or suspected malpresentation of fetus

638

4392

1.04

0.39

1.1

0.85

0.87

g/l

1.33

638

4382

Congenital aortic valve stenosis

1.38

0.39

1.1

1.2

0.93

0.90

g/l

—

Other complications of labour and delivery, not elsewhere classified

328

3049

0.95

0.39

1.0

1.1

0.82

0.84

g/l

1.57

328

3043

Dislocation, sprain and strain of joints and ligaments of head

853

0.90

0.39

1.1

1.2

0.87

0.88

g/l

0.12

853

Clubfoot

203

0.78

0.39

1.1

0.90

0.92

g/l

0.09

203

Congenital malformations of the urinary system

916

0.90

0.39

1.6

1.2

0.84

0.88

g/l

1.10

916

Other diseases of peritoneum

516

0.87

0.38

1.4

1.2

0.86

0.90

g/l

0.40

516

Benign neoplasm: Mediastinum

1.40

0.38

2.4

1.3

0.99

0.88

g/l

—

Use of cabergoline

225

0.79

0.38

1.2

1.1

0.82

0.88

g/l

0.75

225

Oher contracture of tendon (sheath)

1.40

0.38

1.0

1.3

0.71

0.92

g/l

—

Other specified/unspecified deforming dorsopathies

355

0.84

0.38

1.2

0.88

0.91

g/l

0.34

355

Malnutrition

170

0.76

0.38

1.1

1.2

0.75

0.91

g/l

1.93

170

Wilms' tumor, including Hilmo

1.40

0.38

1.0

1.2

1.02

0.93

g/l

—

Malignant neoplasm of gallbladder, including Hilmo

1.40

0.38

1.4

1.1

0.92

0.85

g/l

—

Meningococcal infection

147

0.74

0.38

1.0

1.1

0.95

0.92

g/l

0.22

147

Anisometropia and aniseikonia

420

1.15

0.38

1.1

1.2

0.82

0.90

g/l

1.72

420

Other congenital malformations of male genital organs

113

0.70

0.38

1.0

1.1

0.88

0.91

g/l

—

113

Neuroendocrine tumor and carcinoma of lung

1.33

0.38

2.4

1.3

0.98

0.91

g/l

—

Congenital malformations of spine and bony thorax, including avohilmo

115

0.69

0.38

1.0

1.2

0.94

0.91

g/l

—

115

Other and unspecified injuries of neck

152

1.26

0.38

1.0

1.1

0.80

0.87

g/l

0.81

152

Lymphangioma, anys site

134

1.28

0.38

1.2

1.1

1.01

0.91

g/l

0.76

134

Polymorphous light eruption

125

1.30

0.37

1.0

1.1

0.94

0.89

g/l

0.25

125

Alcoholic gastritis

147

0.74

0.37

1.8

1.1

0.93

0.91

g/l

0.15

147

Villonodular synovitis (pigmented)

134

1.28

0.37

1.2

1.1

0.88

0.93

g/l

0.33

134

Other and unspecified bullous disorders

112

0.71

0.37

1.4

1.1

0.95

0.88

g/l

—

112

Benign neoplasm: Bones of skull and face

134

1.28

0.37

1.3

1.2

0.83

0.89

g/l

0.95

134

Other conjunctival vascular disorders and cysts

257

0.81

0.37

1.9

1.2

0.90

0.89

g/l

0.04

257

Follicular adenocarcinoma of thyroid gland

1.41

0.37

1.0

1.2

0.95

0.87

g/l

—

Third [oculomotor] nerve palsy

158

0.76

0.37

1.4

1.2

0.85

0.91

g/l

0.36

158

Respiratory tuberculosis, confirmed

113

0.70

0.37

1.1

1.2

0.79

0.88

g/l

—

113

Migraine without aura and triptan purchases

434

4518

0.96

0.37

1.1

0.87

g/l

0.06

434

4510

Unspecified visual impairment (binocular)

169

0.76

0.37

1.1

0.85

0.89

g/l

0.33

169

Localized scleroderma [morphea]

180

0.77

0.37

1.1

0.97

0.89

g/l

0.68

180

Uterine polyps

469

2852

0.96

0.37

1.1

1.2

0.89

0.88

g/l

0.28

469

2841

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

116

0.68

0.37

1.0

1.1

0.90

0.91

g/l

—

116

Congenital malformations of the nervous system

439

0.86

0.37

1.2

1.1

0.89

0.90

g/l

0.07

439

Neuroendocrine tumor and carcinoma of small intestine

116

0.68

0.37

1.5

1.2

1.01

0.92

g/l

—

116

Respiratory tuberculosis, bacteriologically and histologically confirmed

115

0.69

0.37

1.1

1.2

0.79

0.88

g/l

—

115

Osteonecrosis due to drugs

116

0.69

0.37

1.4

1.2

0.71

0.91

g/l

—

116

Tuberculosis of other organs

116

0.69

0.37

1.0

1.2

0.84

0.91

g/l

—

116

Other and unspecified disorders of binocular movement

1.38

0.37

1.2

1.1

0.83

g/l

0.02

185

0.78

0.37

1.0

0.84

0.80

g/l

0.28

185

Other diseases of gallbladder

440

1.14

0.37

1.5

1.2

0.87

0.90

g/l

0.58

440

Accidental poisoning by and exposure to other gases and vapours

1.28

0.36

1.0

1.1

0.91

0.90

g/l

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.61

0.36

1.0

1.1

0.87

0.96

g/l

—

Nail dystrophy

1.28

0.36

1.3

1.2

0.81

0.91

g/l

—

Acute hepatitis B

0.63

0.36

1.0

1.2

0.82

0.89

g/l

—

Enteritis due to Yersinia enterocolitica

0.65

0.36

1.0

1.2

0.82

0.89

g/l

—

Sequelae of burns, corrosions and frostbite

0.63

0.36

1.4

1.1

0.75

0.92

g/l

—

Disorders of pituitary gland, other and/or unspecified

0.65

0.36

1.2

1.1

0.89

g/l

—

Acute hepatitis B, including avohilmo

0.62

0.36

1.0

1.2

0.82

0.89

g/l

—

Bulimia nervosa (incl. atypical)

838

0.90

0.36

1.1

0.80

0.84

g/l

0.90

838

Other and unspecified acquired haemolytic anaemias

1.34

0.36

2.4

1.1

0.92

0.93

g/l

0.03

Accessory breast

122

0.73

0.36

1.0

1.1

0.83

0.89

g/l

—

122

Short stature starting before birth

1.45

0.36

1.0

0.95

0.86

g/l

—

ILD medications: azathioprine

309

3238

0.95

0.36

1.6

1.1

0.87

0.89

g/l

1.13

309

3232

Use of amantadine

190

0.78

0.36

1.0

1.2

0.78

0.91

g/l

2.05

190

Hypoplasia of dental enamel, prenatal , including avohilmo

1.44

0.36

1.2

0.74

0.80

g/l

—

Folate deficiency anaemia

0.64

0.36

2.0

1.2

0.66

0.89

g/l

—

Pediculosis and phthiriasis, including avohilmo

125

0.71

0.36

1.0

1.2

1.04

0.88

g/l

—

125

Benign neoplasm: Other parts of oropharynx

108

1.31

0.36

1.6

1.1

0.89

0.91

g/l

0.12

108

Hepatomegaly and splenomegaly, not elsewhere classified

135

1.27

0.36

1.7

1.1

0.87

0.89

g/l

0.12

135

Burn and corrosion of wrist and hand

795

0.90

0.35

1.3

1.1

0.89

g/l

0.06

795

Melanocytic naevi of other and unspecified parts of face

108

996

1.09

0.35

1.3

1.2

0.83

0.88

g/l

1.63

108

996

Infection due to other mycobacteria

126

0.71

0.35

1.0

1.2

1.02

0.93

g/l

—

126

Scissor bite

363

1.15

0.35

1.3

1.1

0.88

0.85

g/l

0.33

363

Primary ovarian failure

415

0.86

0.35

1.2

1.1

0.93

0.86

g/l

0.82

415

Hodgkin lymphoma, hilmo

426

0.86

0.35

1.2

1.1

0.89

0.90

g/l

0.03

426

Fourth [trochlear] nerve palsy

222

0.81

0.35

1.1

1.2

0.90

0.91

g/l

0.06

222

Gingival hyperplasia

479

0.87

0.35

1.9

1.2

0.84

0.91

g/l

1.42

479

222

0.81

0.35

1.1

1.0

0.83

0.79

g/l

0.36

222

Perioral dermatitis

462

1.13

0.34

1.2

0.83

0.88

g/l

0.68

462

Fall involving bed

167

0.78

0.34

1.1

1.3

0.84

0.89

g/l

0.35

167

Galactorrhea

221

0.81

0.34

1.1

0.84

0.87

g/l

0.27

221

Benign neoplasm: Skin of lower limb, including hip

372

0.86

0.34

1.3

1.2

0.92

0.90

g/l

0.13

372

Use of peginterferon beta-1a

0.69

0.34

1.2

1.1

0.89

0.85

g/l

—

Benign neoplasm: Vulva

232

0.81

0.34

1.3

1.2

0.93

0.91

g/l

0.09

232

Disorder of external ear, unspecified

520

0.88

0.34

1.3

1.2

0.88

0.90

g/l

0.21

520

Congenital deformities of hip

285

0.83

0.34

1.0

1.1

0.88

0.86

g/l

0.14

285

Acanthosis nigricans

1.32

0.33

1.0

1.2

0.87

0.85

g/l

—

Onycholysis

0.67

0.33

1.2

1.1

0.97

0.90

g/l

—

Drug-induced polyneuropathy

0.68

0.33

1.5

1.2

0.88

0.94

g/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

303

1.16

0.33

1.2

1.1

0.84

0.87

g/l

0.48

303

Other benign neoplasm of uterus: Other parts/unspecified

0.68

0.33

1.0

1.2

0.97

0.90

g/l

—

Lower leg

1.37

0.33

1.0

1.1

1.04

0.88

g/l

—

Granuloma annulare

209

0.81

0.32

1.2

1.1

0.81

0.89

g/l

1.07

209

Other bursal cyst

192

1.21

0.32

1.1

1.2

0.84

0.91

g/l

0.57

192

Melanoma in situ of other and unspecified parts of face

1.28

0.32

1.2

1.4

0.92

0.86

g/l

—

Other abnormalities of plasma proteins

143

0.76

0.32

1.7

1.1

0.86

0.91

g/l

0.22

143

Benign neoplasm: Tongue

295

0.84

0.32

1.4

1.2

0.83

0.91

g/l

0.95

295

Liveborn infants according to place of birth

102

1.28

0.32

1.4

1.0

0.78

0.79

g/l

0.16

102

Vitiligo

219

0.81

0.32

1.3

1.1

0.87

0.90

g/l

0.34

219

Delayed milestone in childhood

148

0.78

0.32

1.2

1.1

0.99

0.82

g/l

2.85

148

0.72

0.32

1.0

1.1

0.97

0.91

g/l

—

Endometriosis of pelvic peritoneum

361

3154

1.04

0.31

1.1

0.89

0.87

g/l

1.38

361

3148

Deficiency of other B group vitamins

208

0.81

0.31

1.4

1.2

0.83

0.90

g/l

0.79

208

Acute inflammation of orbit

0.71

0.31

1.7

1.1

0.80

0.93

g/l

—

Juvenile Open Angle Glaucoma

100

0.69

0.31

1.4

1.1

0.85

0.89

g/l

—

100

Squamous cell neoplasms and carcinoma of cervix

0.71

0.31

1.0

1.2

1.01

0.89

g/l

—

Injuries involving multiple body regions

663

0.90

0.31

1.1

1.2

0.88

0.89

g/l

0.18

663

Benign neoplasm: Parathyroid gland

0.71

0.31

1.0

1.2

1.05

0.91

g/l

—

Juvenile cataract

1.36

0.31

1.0

1.1

0.84

0.88

g/l

—

Postzoster neuralgia

0.72

0.31

1.3

0.89

g/l

—

Injury of blood vessels of thorax

1.31

0.31

2.3

1.1

0.97

0.93

g/l

—

Exposure to ignition of highly flammable material

1.35

0.31

1.0

1.2

0.94

g/l

—

Primary amenorrhea

120

1.26

0.30

1.3

1.1

0.77

0.80

g/l

0.24

120

Drug-induced osteoporosis

129

1.25

0.30

2.1

1.2

0.88

0.93

g/l

0.56

129

Erythema multiforme

315

1.15

0.30

1.4

1.2

0.84

0.90

g/l

1.12

315

Congenital deformities of hip, including avohilmo

335

0.86

0.30

1.0

1.1

0.86

0.87

g/l

0.08

335

Explosion of other materials

1.29

0.30

1.0

1.1

0.80

0.91

g/l

—

Pyogenic arthritis

912

0.92

0.30

1.3

1.2

0.87

0.90

g/l

0.74

912

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1038

9197

0.98

0.30

1.1

0.88

0.87

g/l

0.73

1032

9176

Inflammatory diseases of prostate (prostatitis)

176

1860

0.94

0.30

1.2

0.88

0.91

g/l

0.88

176

1854

Acute mastoiditis

163

0.79

0.30

1.2

1.1

0.88

0.91

g/l

0.21

163

Other injuries of upper limb, level unspecified

174

0.80

0.30

1.4

1.1

0.88

0.89

g/l

0.04

174

Myotonic disorders

130

0.76

0.30

1.9

1.1

0.79

0.92

g/l

—

130

Benign neoplasm: Other/unspecified site

174

0.80

0.30

1.1

1.2

0.90

g/l

0.01

174

Chromomycosis and phaeomycotic abscess, including avohilmo

1.26

0.30

1.3

1.1

0.94

0.85

g/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

101

1.28

0.29

1.1

0.86

0.81

g/l

0.42

101

Beningn neoplasm: Meninges, unspecified

130

0.77

0.29

1.0

1.2

0.82

0.89

g/l

—

130

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

472

0.89

0.29

1.5

1.2

0.92

0.91

g/l

0.11

472

Sleep apnoea, including avohilmo

2448

14581

1.02

0.29

1.2

0.90

0.89

g/l

0.67

2434

14544

Congenital malformations of breast, including avohilmo

408

0.88

0.29

1.2

0.81

0.85

g/l

0.57

408

Exfoliative dermatitis

107

0.74

0.29

1.0

1.1

0.78

0.91

g/l

—

107

Dependence on enabling machines and devices, not elsewhere classified

106

0.75

0.29

1.5

1.1

0.94

0.87

g/l

—

106

Arthropathy in Crohn disease

184

0.81

0.29

1.7

1.1

0.83

0.91

g/l

1.49

184

Inflammation of lacrimal passages (chronic)

106

0.75

0.29

1.1

1.2

0.96

0.89

g/l

—

106

Portal vein thrombosis

176

1.20

0.29

3.1

1.2

0.96

0.92

g/l

0.27

176

Cholesteatoma of external ear

1.23

0.29

1.1

1.2

0.81

0.89

g/l

—

Use of ropinirole

249

0.84

0.29

1.3

0.86

0.92

g/l

0.88

249

Other diseases caused by chlamydiae

259

0.84

0.29

1.5

1.1

0.88

0.92

g/l

0.46

259

Benign neoplasm: Lip

195

0.82

0.29

1.2

1.00

0.89

g/l

0.70

195

Patellar tendinitis

450

1.12

0.29

1.2

1.1

0.88

0.90

g/l

0.37

450

Von Willebrand disease

216

0.83

0.28

1.0

1.1

0.88

g/l

0.04

216

Polymyositis

1.31

0.28

1.3

1.2

0.99

0.90

g/l

0.45

Carcinoma in situ of rectum

103

1.27

0.28

1.5

1.3

0.96

0.91

g/l

0.26

103

Left hemicolectomy

129

0.77

0.28

1.2

1.00

0.90

g/l

—

129

Malignant neoplasm of testis

364

0.87

0.28

1.2

1.1

0.98

0.93

g/l

0.45

364

Melanocytic naevi of lip

118

0.76

0.28

1.0

1.2

0.86

0.92

g/l

—

118

Varus deformity, not elsewhere classified

172

0.81

0.28

1.1

1.2

0.83

0.92

g/l

0.81

172

Pigmented purpuric dermatosis

119

0.75

0.27

1.2

1.1

0.92

0.91

g/l

—

119

Adult respiratory distress syndrome

118

0.76

0.27

1.0

1.1

0.97

0.89

g/l

—

118

Dermatopolymyositis (FG)

161

0.80

0.27

1.7

1.2

0.97

0.91

g/l

0.30

161

Scar conditions and fibrosis of skin

701

1.09

0.27

1.2

1.1

0.84

0.89

g/l

0.99

701

Caries in Clefts patients

215

1.17

0.27

1.2

1.1

0.93

0.90

g/l

0.32

215

Complications specific to multiple gestation

1.28

0.27

1.1

1.2

0.92

0.85

g/l

0.72

Ulcer of vagina/vulva

437

0.89

0.27

1.1

1.2

0.86

g/l

0.03

437

Cleft lip

0.68

0.27

1.0

1.1

0.86

0.88

g/l

—

Melanoma in situ of upper limb, including shoulder

1.22

0.27

1.9

1.1

1.01

0.86

g/l

—

Crohn disease (strict definition, all UC cases excluded)

100

1070

0.93

0.27

1.2

0.88

0.89

g/l

0.24

100

1070

Congenital deformities of feet, including avohilmo

822

0.92

0.27

1.2

1.1

0.89

g/l

0.01

822

Arnold-Chiari syndrome

150

1.21

0.27

1.2

0.85

0.87

g/l

0.08

150

Disorders of oesophagus in diseases classified elsewhere

159

1.20

0.27

1.7

1.2

0.88

0.91

g/l

0.29

159

Premenstrual syndrome

352

0.87

0.26

1.1

0.86

g/l

0.03

352

Benign neoplasm of other and unspecified sites

426

0.89

0.26

1.2

0.89

0.91

g/l

0.15

426

Injury of blood vessels at lower leg level

0.67

0.26

1.6

1.2

0.88

0.92

g/l

—

Mesial bite

141

1.22

0.26

1.0

1.1

0.89

0.85

g/l

0.55

141

Amoebiasis

0.67

0.26

1.0

1.1

0.86

0.90

g/l

—

Other and unspecified spinal muscular atrophies

0.67

0.26

1.0

1.1

0.96

0.89

g/l

—

Congenital lens malformations

1.26

0.26

1.1

0.91

0.87

g/l

—

Palindromic rheumatism

127

0.78

0.26

1.1

1.2

0.81

0.91

g/l

—

127

Other disorders of bone density and structure

456

0.90

0.25

1.1

0.91

0.90

g/l

0.05

456

Other chondrocalcinosis

1.24

0.25

1.2

0.84

0.90

g/l

—

Other encephalitis

414

0.89

0.25

1.3

1.1

0.95

0.91

g/l

0.48

414

Chronic iridocyclitis

768

0.92

0.25

1.2

0.89

g/l

0.02

768

Achalasia of cardia

181

0.82

0.25

1.3

1.1

0.94

0.91

g/l

0.44

181

Other disorders of pigmentation

540

1.10

0.25

1.3

1.2

0.89

0.90

g/l

0.08

540

Other superficial mycoses

466

0.90

0.25

1.1

0.92

0.89

g/l

0.28

466

Diseases of salivary glands

632

6166

1.03

0.25

1.2

0.88

0.89

g/l

0.39

627

6150

Other disorders of thyroid

151

1.20

0.25

1.5

1.2

0.80

0.91

g/l

1.36

151

Benign neoplasm of male genital organs

207

1.16

0.25

1.1

1.2

0.95

0.94

g/l

0.03

207

Coarctation of the aorta

151

1.20

0.25

1.1

1.2

0.83

0.91

g/l

1.26

151

Birth trauma

1.21

0.25

1.2

1.1

0.88

0.82

g/l

—

Generalized skin eruption due to drugs and medicaments

539

0.91

0.25

1.5

1.2

0.92

0.89

g/l

0.33

539

Other congenital malformations of circulatory system

382

0.89

0.25

1.3

1.2

0.84

0.90

g/l

1.03

382

Cutaneous lupus erythematosus

266

0.86

0.25

1.3

1.2

0.84

0.91

g/l

0.65

266

All dysplastic lesions of the cervix uteri, vagina or vulva

762

7595

0.98

0.25

1.2

1.1

0.86

0.87

g/l

0.26

757

7583

Diastasis of muscle

180

0.83

0.24

1.0

1.2

0.88

g/l

0.03

180

Mastocytosis

1.18

0.24

1.8

1.1

0.79

0.86

g/l

—

Prepatellar bursitis

818

0.93

0.24

1.2

0.89

0.91

g/l

0.28

818

Malignant neoplasm of base of tongue, including Hilmo

1.27

0.24

1.8

1.2

0.98

0.89

g/l

0.64

Hyperprolactinaemia, drug-induced

0.73

0.24

1.0

1.2

0.87

0.90

g/l

—

Hand

0.72

0.24

1.3

1.1

1.01

0.87

g/l

—

Toxoplasmosis, including avohilmo

0.73

0.24

1.2

1.1

0.74

0.89

g/l

—

Other and unspecified syphilis, including avohilmo

0.69

0.24

1.2

1.1

1.05

0.87

g/l

—

Neuroendocrine tumor and carcinoma of pancreas

1.29

0.24

1.1

1.2

0.75

0.91

g/l

—

Melanocytic naevi of ear and external auricular canal

0.72

0.24

1.0

1.2

0.82

0.87

g/l

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Apolipoprotein B [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS